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Over eighty-five thousand Americans are currently on the national
waitlist to receive kidneys, livers, hearts or other human organs due to the
failure of their own. Sadly, over half of these people will die while waiting
for the miracle of life to arrive. Some will travel to other countries to pur-
chase organs on the black market in a last ditch effort to save their lives. All
of those involved wish that finding an organ would be far easier than it is
today.
Since the passage of Al Gore's National Organ Transplant Act, it has
been illegal in the United States to sell human organs, although the same
cannot be said for human tissues, blood plasma, ova, and sperm. Morality
and distributive justice concerns form the backbone of traditional argu-
ments opposing organ sales, as many Americans find it unacceptable to
"purchase life." The poor would be exploited and pressured into selling
organs to escape debt, often with little knowledge of the risks they incurred
and the costs that they might later impose on society's health care system.
While these are legitimate fears, we must also be cognizant of the
ramifications of our public policy choices. Since thousands die each year
while waiting for organs that never arrive, we must explore incentives that
can change this terrible outcome. Regulated markets in organ sales could go
far to safeguard against abuses while preserving their benefits. Distributive
justice concerns could be partially remedied by subsidizing the purchase of
human organs for the poor, and by insisting that potential sellers be fully
educated about the increased risks they incur. To compensate for the exter-
nalities imposed on America's health care system, a portion of organ sale
receipts could be placed into an insurance pool that guarantees that those
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whose health later deteriorates will be cared for without burdening society's
limited resources.
Moreover, if conscience dictates that living-donor organ sales must
never occur, it is incumbent upon society to focus on other methods of in-
centivizing organ availability. By giving priority to Americans who are
willing to donate organs themselves, we could overcome the paradox be-
tween the widespread public support for donation and the reality that rela-
tively few people affirmatively sign up today. "Futures markets," which
allow payment now for organs harvested only at death, can overcome con-
cerns regarding the risks and abuses posed by taking organs from living
individuals. More modestly, the law could permit reimbursement of the
donor's family for burial expenses if they agree to part with a deceased
loved one's organs. In addition, state governments could provide tax breaks
to encourage donation, or waive driver's license fees for those who opt in.
If any form of monetary inducement runs afoul of federal law, far
more attention must be paid to the concept of "paired organ exchanges," an
ingenious method of facilitating organ swaps that does not involve any fi-
nancial consideration. In addition, basing waiting list priority on a person's
own willingness to donate would inspire millions of Americans to opt in to
donation who today have not yet taken the trouble to sign up. Furthermore,
rather than ask Americans to opt in to donation, we could presume consent
unless otherwise stated to take advantage of the public consensus in favor
of donation that often goes unacted upon. Moreover, hospitals and health
care professionals should be better trained to request donations from dece-
dents' families in a manner sensitive to the grieving process, and the media
must do a better job of increasing public awareness of the crisis than that
which it does today.
In sum, we must act aggressively to improve America's organ dona-
tion law and procurement policy. If we do not do so, tens of thousands will
pay for our failures with their lives.
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INTRODUCTION
A small Bosnian newspaper recently carried an ad that read, "[s]trong,
healthy 35-year-old man, married, 2 children, offers kidney for sale. Blood
type A-positive."' Some readers might find this shocking and offensive.
The same cannot be said for the Brooklyn woman who was recently told by
her physician, "get a kidney any way [you can], or expect to die."2 Situa-
tions like these are reproduced thousands of times over across the world
today, as individuals in dire need are faced with terrible choices. For some,
poverty drives them to sell their organs, while for others, imminent death
drives them to buy.
In just the time it takes to read this paper, one American will die be-
cause she could not find a suitable organ in time.3 Currently, over 85,000
people in the U.S. are on the national waitlist for an organ-approximately
60,000 in need of a kidney, 17,000 seeking a liver, 4,000 desperate for a
lung, and 3,500 hoping for a heart. 4 In contrast to the overwhelming de-
mand, the number of human organs actually supplied is far more muted:
only 25,000 transplants occurred in 2003, with organs reaped from a mere
13,000 individuals.5 Those stark numbers are made even more alarming by
the sad reality that over 6,000 Americans die every year while waiting for a
transplant.6 Some Americans choose to travel abroad in a last-ditch effort to
I See Kidneys on Sale in Bosnia, THE STATESMAN, Jan. 22, 2002, available at 2002 WL 3378308
(detailing the newspaper kidney advertisement and the illegal organ trade).
2 Larry Rohter, Tracking the Sale of a Kidney on a Path of Poverty and Hope, N.Y. TIMES, May
23, 2004, § 1, at 1 (internal quotation marks omitted). Rohter recounts the tale of Alberty Jose da Silva,
the impoverished Brazilian son of a prostitute, who showed the scars where a kidney and rib were
removed in exchange for $6,000. ld. Da Silva viewed the sale as an escape from poverty, and the
Brooklyn recipient viewed it as an escape from certain death. See id.
3 Approximately 17 individuals die each day while waiting for an organ, translating to one person
every 1.4 hours. Living Legacy Registry, Donation Statistics, a t
http://livinglegacyregistry.org/leam/statistics/index.html (last visited Nov. 3, 2004) [hereinafter Living
Legacy Registry].
4 The Organ Procurement and Transplantation Network ("OPTN"), Data, at
http://www.optn.org/data/ (last visited Nov. 3, 2004). The transplant community is joined under a na-
tionwide umbrella called the Organ Procurement and Transplantation Network. OPTN, About OPTN, at
http://www.optn.org/optn/ (last visited Nov. 3, 2004). The United Network for Organ Sharing
("UNOS") administers the OPTN under contract with the U.S. Department of Health and Human Serv-
ices. Id.
5 See OPTN, at http://optn.org/latestData/viewDataReports.asp (reporting national data, includ-
ing the number of transplants per state since 1988). See also ORGAN PROCUREMENT TRANSPLANTATION
NETWORK & SCIENTIFIC REGISTRY OF TRANSPLANT RECIPIENTS, OPTN/SRTR 2003 ANNUAL REPORT
I-1, available at http://www.optn.org/AR2003/Chapter-lAR Print.pdf (last visited Nov. 3, 2004).
6 See Living Legacy Registry, supra note 3. These numbers are actually understated because they
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find a black market organ that will allow them to escape death; many more
die wishing they had the option to purchase the kidney they need here in the
U.S.7
Ironically, the severe shortage is not due to a lack of donation-
appropriate organs, but rather, the fact that most of those organs are taken
to the grave by their owners.8 Each year, thousands of Americans die in
ways that would allow for their organs to be harvested, but relatively few of
those individuals are donors.9 In fact, approximately three quarters of the
American public has not opted in to organ donation, and the roughly 25%
who have done so cannot come close to supporting the nation's needs.10
do not include the hundreds of Americans who die after they have become too sick to be candidates for
a transplant. See Alexander Tabarrok, Life-Saving Incentives: Consequences, Costs and Solutions to the
Organ Shortage, THE LIBR. OF ECON. & LIBERTY, 1 (Apr. 5, 2004), a t
http://www.econlib.org/library/Columns/y2004/Tabarrokorgans.html (last visited April 5, 2005).
7 See Eamonn O'Neill, The Cost of Living, THE SCOTSMAN, Mar. 10, 2001, at 14, available at
2001 WL 14095051 (detailing the various illegal markets for kidneys abroad, and noting that 300
Americans travel to foreign countries each year in a last ditch effort to save their lives).
8 See Eric Cohen, Organs for Sale, PUB. INT., 114, 115 (2003) (reviewing DAVID L. KASERMAN
& A.H. BARNETT, THE U.S. ORGAN PROCUREMENT SYSTEM: A PRESCRIPTION FOR REFORM) (stating
that "[d]eath produces more usable bodies than [the] current system is able to exploit and more usable
organs than existing organ demand"); S.Rep.No. 98-382, at 2 (1984), reprinted in 1984 U.S.S.C.A.N.
3975, 3976 (noting that organs are only harvested from less than 15% of individuals who die in ways
that would be suitable for donation). Further, Peter Young reports that while 10,000 to 12,000 people
die in a manner that allows donation, organs are collected from only one-third. Peter S. Young, Moving
to Compensate Families in the Human-Organ Market, N.Y. TIMES, July 8, 1994, at B7.
9 The National Kidney Foundation estimates 10,000 to 14,000 people who die each year meet the
criteria for organ donation, but less than half of that number become actual organ donors. National
Kidney Foundation, Twenty-Five Facts About Organ Donation and Transplantation, at
http://www.kidney.org/general/news/factsheet.cfmn?id=30 (last visited Nov. 4, 2004). Henry Hansmann
adds that roughly 20,000 Americans die annually under circumstances that would make their organs
suitable for harvesting, but only about 15% donate their organs. Henry Hansmann, The Economics and
Ethics of Markets for Human Organs, 14 J. HEALTH POL., POL'Y & L. 57, 60 (1989). Furthermore,
studies of organ procurement efficiency from those who died in ways that would allow donation indi-
cated that only 37% to 59% of viable organs were actually harvested. See R.W. Evans et al., The Poten-
tial Supply of Organ Donors: An Assessment of the Efficiency of Organ Procurement Efforts in the
United States, 267 J. AMER. MED. ASS'N. 239, 242 (1992); see also Edward Guadagnoli et al., Potential
Organ-Donor Supply and Efficiency of Organ Procurement Organizations, 24 HEALTH CARE FtNANC.
REV. 101, 104 (2003) (finding that the procurement efficiency for a majority of organ procurement
organizations ("OPOs") ranged between 30% to 40%, meaning that only three to four in ten suitable
organs were actually donated).
10 The number of Americans who support organ donation versus those who have actually signed
up as donors varies somewhat from survey to survey. A 1993 poll indicated that just 28% of Americans
had granted permission for organ donation on their driver's license or on a signed donor card, while
55% said they would be willing to be donors. See The Gallup Organization, Inc., The American Public's
Attitudes Toward Organ Donation and Transplantation: A Survey (1993), available at
http://www.transweb.org/reference/articles/gallupsurvey/gallupchap3.html (last visited Nov. 5, 2004);
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This article addresses the growing organ shortage in America, ana-
lyzes current donation and procurement law, and explores both monetary
and nonmonetary incentives aimed at eliminating the worsening crisis. Part
I details the law governing human organ donation. Under both the Uniform
Anatomical Gift Act ("UAGA")1' and the National Organ Transplant Act
("NOTA"), 12 no donor of a human organ may receive "valuable considera-
tion" for providing it.' 3 Congress' intention was simply that the organ re-
cipient be given the "gift" of life-not one which she had to purchase on
the market. In reality, the consequences of the Act bear little resemblance to
its initial intent. Organ scarcity has been the unintended result, leading to a
thriving global black market in human organ sales.
Part II explores the traditional arguments that scholars and legislators
have raised against legalizing the sale of human organs. Notions of moral-
ity, distributive justice, imperfect information, and negative externalities
are routinely offered to justify the current law prohibiting sales. Part III
explores some of the limitations of the above rationales, offering reasons
why properly regulated organ sales may not be as farfetched or offensive as
some initially think. I will offer suggestions for responsible regulation of
sales to guard against the abuses and exploitation rampant on the black
market, and to ensure that a seller's decision is truly voluntary, fully in-
formed, competent, and enduring.
Part IV proposes and analyzes incentive-based solutions to cure the
organ crisis in America. Monetary incentives short of outright sale by liv-
ing donors would go far towards boosting organ supply while reducing the
concerns raised by open markets in organs. Some scholars have suggested
"futures markets,"' 4 allowing individuals to receive remuneration today in
see also Cass R. Sunstein and Richard H. Thaler, Libertarian Paternalism Is Not an Oxymoron, 70 U.
CHI. L. REv. 1159, 1192, n.124 (2003) (citing to results of 1993 Gallup poll). Hansmann cites to a 1985
poll that showed that that only 17% of Americans had completed organ donor cards. See Hansmann,
supra note 9, at 60 n.9. A 1999 study found that 81% of Americans support organ donation, but only
42% reported that they had actually signed an organ donor card. See Pew Research Center for the Peo-
ple & the Press, Organ Donor Topline (May 12-16, 1999) at http://people-
press.org/reports/print.php3?PagelD=298 (last visited Nov. 5, 2004).
11 Unif. Anatomical Gift Act §§ 1-11 (amended 1987), 8A U.L.A. 99 (1968).
12 42 U.S.C. §§ 273-274e (2000). NOTA was proposed by then-congressman Al Gore partially in
response to growing concerns that a market in human kidneys was about to be formed by Dr. H. Barry
Jacobs, founder of the International Kidney Exchange. See Walter Sullivan, Buying of Kidneys of Poor
Attacked, N.Y. TIMES, Sept. 24, 1983, § 1, at 9.
13 See UNIF. ANATOMICAL GIFT ACT § 10(a), 8A U.L.A. 62 (1987); 42 U.S.C. § 274e(a) (2000).
14 See Lloyd R. Cohen, Increasing the Supply of Transplant Organs: The Virtues of a Futures
Market, 58 GEO. WASH. L. REv. 1, 1 (1989); see also LLOYD R. COHEN, INCREASING THE SUPPLY OF
TRANSPLANT ORGANS: THE VIRTUES OF AN OPTIONS MARKET (R.G. Landes 1995); Hansmann, supra
note 9, at 62.
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exchange for agreeing to have their organs donated at death.'5 A few states
have considered tax deductions for donors, 16 and some even offer nominal
amounts of money to individuals who opt in to donation when renewing
their driver's licenses. 17 By modifying and combining some of these ideas, I
will propose ways that we could dramatically raise organ donor participa-
tion rates while staying within the confines of NOTA and UAGA.
Moreover, there are numerous non-monetary incentives that U.S. leg-
islators and public policy makers need to explore in earnest. Basing waiting
list priority on the patient's own willingness to donate would inspire mil-
lions of Americans to opt in to donation who today have not yet taken the
trouble to sign up.18 "Paired organ exchanges" are also capable of creating
moneyless markets that incentivize donation by capitalizing on families'
self-interest to preserve the life of a loved one even where relatives are not
a good biological match.19 Establishing a national donor database would be
15 See Hansmann, supra note 9, at 62-63. Cohen proposes payment to the seller's beneficiary at
death rather than payment to the seller during her lifetime. See Lloyd Cohen, supra note 14, at 33. He
has also argued for a broader market-based system to increase organ supply and provide for a fairer
allocation of organs to patients. See Lloyd R. Cohen, Increasing Supply, Improving Allocation, and
Furthering Justice and Decency in Organ Acquisition and Allocation: The Many Virtues of Markets, 1
GRAFT 122 (1998).
16 See Jo Napolitano, Wisconsin Senate Approves Tax Deduction for Organ Donors, N.Y. TIMES,
Jan. 23, 2004, at A12. Napolitano notes that Wisconsin is not the first state to attempt to create incen-
tives to spur organ donation-Indiana is considering nearly identical legislation, and the Kansas legis-
lature thought about providing tax breaks for blood and organ donation in 2000. Id. However, the Kan-
sas bill stalled out when the state's attorney general authored an opinion that the proposed legislation
would run afoul ofNOTA. Id.
17 See Tabarrok, supra note 6 (noting that Georgia offers $9 to residents who agree to become
organ donors at the time of driver license renewal, but that this incentive is in danger of being rescinded
in an attempt to boost state revenue). Connecticut is among the states that have considered similar
measures. See Hansmann, supra note 9, at 63.
18 This concept has been put into practice by LifeSharers, an organization that encourages people
to become member donors by offering them priority to the organs of fellow members should they ever
need one-i.e., priority based on one's own willingness to donate. See LifeSharers, at
http://www.lifesharers.con/ [hereinafter LifeSharers] (last visited Nov. 5, 2004). Further, it seems
intuitively fair that, all else equal, organ priority should be given to those individuals who themselves
are willing to make the same sacrifice to save the lives of others in need. Unfortunately, 70% of organs
transplanted today go to recipients who are not themselves signed up as donors. See id.
19 Michael T. Morley, Increasing the Supply of Organs for Transplantation Through Paired
Organ Exchanges, 21 YALE L. & POL'Y REV. 221, 223-24 (2003); David Wessel, Easing the Kidney
Shortage, WALL ST. J., June 17, 2004, at BI. Paired organ exchanges involve matching families of
patients on the nationwide waitlist who are willing to donate to save a loved one's life but who cannot
do so because they are not good biological matches. By pairing those willing donors with strangers who
are also willing donors but who face the same biological predicament with a loved one of their own, an
organ swap can be arranged that saves two people's lives. Even better, the nonmonetary exchange stays
well within the confines of current law prohibiting the payment of valuable consideration for human
organs.
2004]
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an important additional step in facilitating these organ swaps. 20 Further-
more, presumed consent or required request statutes have the potential to
substantially boost the supply of available organs without requiring any
financial remuneration to donors. 2' Lastly, an aggressive public education
and awareness campaign regarding the crucial need for organs is also es-
sential, as a large majority of Americans support the concept of donation
but simply never take the step to sign up.
2 2
In the final analysis, we must critically analyze the justifications for
the ban on human organ sales and reconsider the dire ramifications that
accompany it. If conscience dictates that we must never allow payment in
exchange for life-saving human organs, we owe a duty to the thousands of
Americans who are dying annually to act aggressively to explore other
ways to save their lives. Utilizing affirmative incentives to accomplish this
purpose should not be overlooked any longer.
I. AN OVERVIEW OF ORGAN DONATION LAW-AND ITS UNINTENDED
CONSEQUENCES
A. The Law: The National Organ Transplant Act and the Uniform Ana-
tomical Gift Act
In 1954, a team of surgeons successfully transplanted the first kidney
from Ronald Herrick to his identical twin Richard who was dying from
20 Morley, supra note 19, at 224.
21 Countries such as Austria, Denmark, France, Poland, Switzerland, Finland, Greece, Italy,
Norway, Spain, and Sweden all presume that their citizens want to donate their organs at death unless
the individual expressly opts out during her lifetime. Sheldon F. Kurtz & Michael J. Saks, The Trans-
plant Paradox: Overwhelming Public Support for Organ Donation vs. Under-Supply of Organs: The
Iowa Organ Procurement Study, 21 J. CORP. L. 767, 778-79 (1996).
22 Id. at 768, 802; Hansmann, supra note 9, at 60 n.9 (citing a 1985 poll showing only 17 percent
of Americans completed donor cards); Pew Research Center for the People and the Press, supra note 10
(noting that 81% of the public supports organ donation but only 42% indicated that they had actually
backed up their beliefs by signing a donor card). At the state level, an online survey by LifeSource
showed that 92% of residents in North Dakota, South Dakota and Minnesota supported the concept of
organ donation, but only 58% have acted upon those intentions. Dave Kolpack, Willing Organ Donors
Not Signing Up, BISMARK TRIBUNE (NORTH DAKOTA), June 26, 2003, at 8A (finding that 93% of North
Dakota citizens approved of organ donation, but less than two-thirds had checked the donor box on their
license); see also Kathleen Longcore & Sharon Emery, One Last Loss: A Willingness to Donate Organs
Isn't Always Enough to Make it Happen, GRAND RAPIDS PRESS, Dec. 7, 2003, at Al. (stating that
"[w]hile public opinion polls [in Michigan] show broad support for organ donation, only about 600,000
Michigan residents-7 percent-are signed up.").
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kidney disease.23 This monumental medical achievement raised the poten-
tial to save thousands of lives, but created a need for novel legal regulation
of the human body.
Historically, there were no common law property rights in human
corpses or the organs that laid therein. 24 Once transplantation became pos-
sible, it was necessary for state and federal legislatures to regulate organ
donations to provide a legal mechanism for proper transfer.25 In 1968, the
23 Susan J. Landers, Transplants: 50 Years of Saving Lives, Feb. 16, 2004, available at
http://www.ama-assn.org/amednews/2004/02/16/hIl20216.htm (last visited April 5, 2005). The earliest
human organ transplant was a 1911 testis allograft, performed by surgeons in the United States. Laurel
R. Siegel, Re-Engineering the Laws of Organ Transplantation, 49 EMORY L.J. 917, 920 (2000). Some
years later, French-born physician Alexis Carrel greatly advanced the art of transplantation by devising
techniques for rejoining blood vessels, discovering rejection, improving transplantation skills and trig-
gering further organ transplant research. Id. In the 1950s, U.S. doctors conducted live human kidney
transplants. By 1967, a South African surgeon performed the first human heart transplant. Id.
Xenotransplantation, or the transplantation of organs from one species to another, also got its start in the
early twentieth century, with much less success. See Xenotransplantation on the Web, at
http://www.xenotransplant.ineu.org/xenotrans/index.htm (last visited April 5, 2005). The concept is far
more controversial than traditional organ transplantation in clinical and ethical circles, as many com-
mentators worry about the unknown health risks and consequences that could be created by intermin-
gling organs from two different species. See Margaret A. Clark, This Little Piggy Went to Market: The
Xenotransplantation and Xenozoonose Debate, 27 J.L. MED. & ETHICS 137, 138-39 (1999); Jack M.
Kress, Xenotransplantation: Ethics and Economics, 53 FOOD & DRUG L.J. 353, 371-79 (1998).
24 English common law did not recognize property rights in human corpses. Siegel, supra note 23,
at 927. In the last few decades in America, however, common law regarding this subject has begun to
evolve. Generally, state courts have bestowed upon family members a quasi-property right in human
corpses, and have found that a relative's property rights allows them to make decisions about organ
donations. See, e.g., Brotherton v. Cleveland, 923 F.2d 477, 481 (6th Cir. 1991) (holding that widow of
deceased had a legitimate claim of entitlement in her husband's body, including his corneas, which was
protected by the due process clause of the Constitution). There have been some limitations placed on
these quasi-property rights, however. Courts have determined that human organs contain no inherent
value, and have therefore not allowed claims for conversion based upon them. See Shults v. United
States, 995 F. Supp. 1270, 1273-1276 (D. Kan. 1998) (holding that a cause of action for conversion is
inappropriate, but that a tort claim such as intentional infliction of emotional distress may be applicable
if the requisite elements were met). Further, a compelling state interest or statutory right granted to the
medical examiner can supercede a relative's property rights to do what she pleases with a loved one's
body. State v. Powell, 497 So.2d 1188 (Fla. 1986) (holding that the state interest in providing sight to
blind citizens is compelling enough to allow removal of corneas from a corpse without notice to the
next of kin). Additionally, the Georgia Supreme Court upheld a statute allowing corneal tissue to be
removed without the consent of the family, reasoning that maintaining public health was one of the
fundamental duties of the state. Georgia Lions Eye Bank, Inc. v. Lavant, 335 S.E.2d 127, 128 (Ga.
1985). For a more thorough treatment of the evolution of thinking regarding property interests in the
human body, see R. Alta Charo, Skin and Bones: Post-Mortem Markets in Human Tissue, 26 NOVA L.
REV. 421 (2002). See also Guido Calabresi, An Introduction to Legal Thought: Four Approaches to
Law and to the Allocation of Body Parts, 55 STAN. L. REV. 2113 (2003); Radhika Rao, Property, Pri-
vacy and the Human Body, 80 B.U. L. REV. 359 (2000).
25 Before federal legislation could be passed, several states adopted their own versions of organ
donation laws. In 1947, California became the first state to regulate the bequeathment of organs. Lloyd
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National Conference of Commissioners on Uniform State Laws
("NCCUSL") drafted the Uniform Anatomical Gift Act ("UAGA"), which
provided for uniform regulation of anatomical gifts and defined persons
who could gift their organs. 26 The UAGA limited the ability to donate or-
gans to the individual upon her death or to her next of kin if the deceased
had not expressed her wishes. If either the decedent or next of kin refused
to consent, then donation could not occur regardless of the hospital's or
physician's wishes. 28 Further, the original UAGA did not explicitly address
the potential for human organ sales, but the use of the word "gift" in the
statute's title was widely interpreted to outlaw them.29 By 1973, every state
had adopted a version of the UAGA.3 °
Nearly twenty years after its passage, NCCUSL amended the UAGA
in 1987 to clarify its intent, and revised certain provisions in an attempt to
spur widespread organ donation-which had yet to materialize. 31 First, the
statute was simplified to ensure that the donor's wishes were followed upon
death rather than overridden by her next of kin.32 Next, the amended
UAGA explicitly banned the sale of organs, and imposed severe penalties
for violations-including possible imprisonment.33 However, there was no
limitation placed on providing "valuable consideration" for the "removal,
R. Cohen, Organ Transplant Market Would Save Lives, NAT'L L.J., Jan. 29, 1996, at A19. Many other
states followed California's example, although the provisions varied. Id. Thus, prior to the UAGA,
organ donation law and policy was far from uniform and in need of federal assistance.
26 UNIF. ANATOMICAL GIFT ACT §§ 1-11 (amended 1987), 8A U.L.A. 94 (1968). The UAGA
provides that an individual of at least eighteen years of age and of sound mind may donate her organs
upon death. See id. at § 2(a). The desire to donate may be evidenced through a will or a signed donor
card. Id. at § 4(a)(b).
27 Id. at § 2(b).
28 Id. at § 2(a)-(c).
29 Cohen, supra note 25. The chairman of the drafting committee did not intend for the UAGA to
expressly prevent organ sales, believing the matter should be "left to the decency of intelligent human
beings." Hansmann, supra note 9, at 58.
30 Hansmann, supra note 9, at 58.
31 UNIF. ANATOMICAL GIFT Act § 6(a)(l)-(3) and comment (1987); see also Siegel, supra note
23, at 933. For an excellent comparison of the 1968 and 1987 Acts, see Lisa E. Douglass, Organ Dona-
tion, Procurement and Transplantation: The Process, The Problems, The Law, 65 UMKC L. REv. 201
(1996).
32 See UNIF. ANATOMICAL GIFT ACT § 2(h). Use of anatomical gifts for transplantation was also
made a higher priority than research or therapy. See id. at § 6(a)(l)-(3) and comment (1987); see also
Siegel, supra note 23, at 933.
33 UNIF. ANATOMICAL GIFT ACt § 10. Violations result in a felony conviction, with the potential
for imprisonment not exceeding five years and a monetary fine of $50,000. See id. However, only
twenty-one states adopted the amended UAGA with the specific prohibitions on organ sales; others still
do not explicitly recognize by statute the prohibition of organ sales included in the 1987 amendments.
See Siegel, supra note 23, at 933.
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processing, disposal, preservation, quality control, storage, transportation or
implantation of a [human organ]. 34 These provisions echoed the recently
enacted National Organ Transplant Act, 35 discussed infra. The revised
UAGA also added provisions requiring that hospitals discuss with adult
patients the option of organ donation, and that they inform family members
of their authority to consent to the harvesting of their deceased relative's
organs.36 Finally, medical examiners were authorized to harvest organs if,
after reasonable efforts, the decedent's family members could not be lo-
cated.
A vital companion to the UAGA, the National Organ Transplant Act
("NOTA") was passed in 1984 in an attempt to better organize and encour-
age organ donations, while clarifying the bounds of acceptable organ pro-
curement practices.37 While numerous advances in medical transplant tech-
nology now allowed human organs to be viable for longer periods of time
and new anti-rejection drugs like cyclosporine increased the transplantation
success rate,38 most usable organs were still being taken to the grave along
with their owners. 39 In fact, at the time of NOTA's passage, nearly 20,000
people were dying annually with organs that were suitable for transplanta-
tion-but only 15% of them were being recovered. 40 In response, an entre-
preneurial physician, H. Barry Jacobs proposed an organ brokerage called
the International Kidney Exchange that would allow sales by both domestic
and international donors to overcome the shortage of organs supplied.4
Talk of an express "organs-for-sale" system did not go over well with the
National Kidney Foundation or American politicians.42 Congress, led by
34 UNIF. ANATOMICAL GIFT ACT § 10(b).
35 42 U.S.C. §§ 2 73-74(g) (2000).
36 UNIF. ANATOMICAL GIFT ACT § 3.
37 42 U.S.C. §§ 2 73-74(g) (2000); Siegel, supra note 23, at 934-35.
38 Siegel, supra note 23, at 921-22. The invention of immunosuppressive drugs in the late 1970s
"led to an explosion in the number of organ transplants in the 1980s and 1990s." Id. Continued drug
development has made rejection even less problematic. Id. at 922. With improved medical technology
and greater success rates-but not enough organs-the situation was ripe for an illegal market to spring
up.
39 S. Rep. No. 98-382 at 2 (1984), reprinted in 1984 U.S.S.C.A.N. 3975, 3976.
40 Id.
41 Sullivan, supra note 12, at 9; Ann McIntosh, Comment, Regulating the "Gift of Life": The
1987 Uniform Anatomical Gift Act, 65 WASH. L. REV. 171, 174 n.30 (1990). Dr. Jacobs proposed the
kidney-for-sale system in order to help alleviate the plight of the 70,000 Americans who were depend-
ent on dialysis machines. Sullivan, supra note 12, at 9. His proposed market included purchasing kid-
neys from people living in underdeveloped countries. Id.
42 See Sullivan, supra note 12, at 9. Dr. Jacobs' proposal drew strong opposition on ethical and
medical grounds from the National Kidney Foundation. Id. He also was not aided by his dubious past,
which included the revocation of his medical license after being convicted of mail fraud in a case related
to Medicare billing. Id.
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then-congressman Al Gore, passed NOTA easily to preserve the "gift" as-
pect of human organ donations,4 3 while at the same time organizing and
encouraging donations to occur in the first place.
To designate the bounds of acceptable organ procurement practice,
NOTA provides: "It shall be unlawful for any person to knowingly acquire,
receive, or otherwise transfer any human organ for valuable consideration
for use in human transplantation if the transfer affects interstate com-
merce."'  Organs were defined in NOTA as "kidney, liver, heart, lung, pan-
creas, bone marrow, cornea, eye, bone, and skin, . . . and any other human
organ specified by the Secretary of Health and Human Services by regula-
tion."45 Thus, Congress began explicitly regulating an area that had been
implicitly regulated in the original UAGA-selling organs was now un-
43 Neal Conan, Talk of the Nation: Ethics and Economics of a Human Organs Trade (NPR radio
broadcast, Dec. 9, 2003). NOTA was passed with very little debate-the Senate Labor and Human
Resources Committee easily concluded that "individuals or organizations should not profit by the sale
of human organs for transplantation." S. Rep. No. 98-382, at 16, reprinted in 1984 U.S.C.C.A.N. at
3982. The Committee noted that because the UAGA was silent regarding organ sales, new legislation
was necessary to clear up any confusion that remained regarding the issue. See id. at 17.
44 42 U.S.C. § 274e(a) (1994). NOTA enforces this prohibition by threatening individuals who
violate the law with a fine of up to $50,000, or imprisonment of five years or less. § 274e(b). Because
laws concerning treatment, consent, and definition of death fall under state law, the prohibition in
NOTA relates solely to "interstate commerce." S. Rep. No. 98-382, at 17, reprinted in 1984
U.S.C.C.A.N. at 3983. However, several famous constitutional law cases have defined "interstate com-
merce" quite broadly. See, e.g., Wickard v. Filburn, 317 U.S. 111 (1942); Heart of Atlanta Motel v.
United States, 379 U.S. 241 (1964). Others have argued, however, that NOTA's outright ban on organ
sales may violate an individual's privacy right under the U.S. Constitution. See Karen Johnson, The Sale
of Human Organs: Implicating a Privacy Right, 21 VAL. U. L. REV. 741, 761-62 (1987). Johnson's
argument runs as follows: there is a fundamental privacy right in decisions regarding medical treatment
as well as those that affect bodily integrity, including what an individual does with her own organs. See
id. Heightened scrutiny and narrow tailoring requirements apply to legislation that affects fundamental
rights. Id. Organ sales also impact a personal right-under Plyler v. Doe, economic legislation that
interferes with personal rights triggers intermediate scrutiny. See id; see also Plyler v. Doe, 457 U.S.
202, 217-18, n. 16 (1981). Intermediate scrutiny demands that there be an important governmental
interest served by the law, and that the limitation imposed be substantially related to achieving that
interest. See Johnson, supra. Some of the government's interests in banning organ sales include: (1)
protecting the mental and physical health of the seller, (2) preserving the quality of transplant organs,
(3) safeguarding the integrity of the medical profession, and 4) minimizing the impact on society due to
the potential for dehumanization. See id. at 757-58. Johnson concludes that during the lifetime of the
donor, the government's interests are likely to be substantial enough to outweigh the wish of the donor
to sell his or her organs. However, once brain death occurs, this is no longer true. Id. at 759. NOTA, in
failing to distinguish between inter vivos sales versus sales that occur after death, may not be narrowly
tailored (as would be required if strict scrutiny applied) or substantially related (as would be required
with intermediate scrutiny) to achieve the governmental interests at stake. Id.; see also Rao, supra note
24, at 387-400 (exploring the connection between privacy and property in the context of the human
body); Charo, supra note 24, at 432; Calabresi, supra note 24, at 2135-37.
45 42 U.S.C. § 274e(c)(1).
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questionably illegal.46 However, just like the revised UAGA promulgated
three years later, NOTA explains that valuable consideration "does not in-
clude the reasonable payments associated with the removal, transplantation,
implantation, processing, preservation, quality control, and storage of a
human organ.', 4 7 This carve-out for organ transplant support services has
spawned the creation of an enormous industry with equally large price tags
attached--even though human organs are not for sale, everything else asso-
ciated with their transplantation most definitely is.4 8 Furthermore, NOTA's
ban on organ sales does not limit the selling of renewable human tissues,
like ova, sperm and blood.49
In addition to NOTA's bedrock prohibition on human organ sales, the
Act was intended to spur procurement of organs through non-financial
means and designed to ensure fair national health policy regarding organ
allocation.5" To that end, NOTA created an elaborate system to foster organ
donation, including the Organ Procurement and Transplantation Network
("OPTN"), a non-profit, privately funded organization charged with for-
mulating standards for organ allocation and systemizing organ matching. 51
Congress mandated the creation of a dual computerized system to facilitate
OPTN's objectives, one which lists all patients requiring transplants and the
other which is designed to match these patients to donors.52 Additionally,
46 See S. Rep. No. 98-382 at 2, reprinted in 1984 U.S.S.C.A.N. at 3978.
47 42 U.S.C. § 274e(c)(2). Further, the "expenses of travel, housing, and lost wages incurred by
the donor of a human organ in connection with the donation of the organ" can also be reimbursed. Id.
48 See Emanuel Thome & Gilah Langer, The Body's Value Has Gone Up; Who Should Profit from
Organs?, N.Y. TIMES, Sept. 8, 1986, at A23 (arguing that the medical team performing the transplant
can reap the full value of the supposedly free organ donation by increasing their prices for other services
to capture the patient's entire willingness to pay); Young, supra note 8 (noting that there is a "big
markup" on transplant support services that accompanies NOTA's ban on human organ sales).
49 The Senate Labor and Human Resources Committee distinguished between the sale of organs
versus blood products because the latter are regenerative and do not pose a threat to the donor's health.
See S. Rep. No. 98-382, at 16-17, reprinted in 1984 U.S.C.C.A.N. at 3982. For a detailed discussion of
the rights and rules associated with the sale of human tissues, see Julia D. Mahoney, The Market for
Human Tissue, 86 VA. L. REV. 163, 167-96 (2000); Judith B. Prowda, Moore v. The Regents of the
University of California: An Ethical Debate on Informed Consent and Property Rights in a Patient's
Cells, 77 J. PAT. & TRADEMARK OFF. SOC'Y. 611, 620-25 (1995).
50 Gail L. Daubert, Comment, Politics, Policies, and Problems with Organ Transplantation:
Government Regulation Needed to Ration Organs Equitably, 50 ADMIN. L. REV. 459, 463 (1998).
51 The Organ Procurement and Transplant Network ("OPTN"), About OPTN, at
http://www.optn.org/optn/ (last visited April 5, 2005). The OPTN was also intended to have an educa-
tional component, sharing information with physicians regarding organ donation. James F. Blumstein,
Government's Role in Organ Transplantation Policy, 14 J. HEALTH POL. POL'Y & L. 5, 13-14 (1989).
The OPTN was expected to conduct studies concerning organ donation and transplants and work to
increase the nation's organ supply. 42 U.S.C. § 274(b)(2)(I)-(K) (1994). The United Network for Organ
Sharing ("UNOS") became the first and only OPTN.
52 42 U.S.C. § 274(b)(A)(i)-(ii); Blumstein, supra note 51, at 13.
20041
GEO. MASON L. REv.
Congress increased funding for organ procurement organizations ("OPOs"),
regional groups which are part of the OPTN and which are responsible for
obtaining organs.53 Congress believed additional OPOs could increase or-
gan supply (and hence transplants) since OPOs are expected to "participate
in systematic efforts, including professional education, to acquire all use-
able organs from potential donors. 54 Once a successful match is made,
OPOs are tasked with procuring and arranging the delivery of organs.55
They are also responsible for working with hospitals to establish organ pro-
curement and donation protocols.56 Thus, OPOs are the legislature's tool of
choice today to increase voluntary organ donations and to ensure that or-
gans are distributed properly.57
53 Siegel, supra note 23, at 935-36. Currently, there are 62 OPOs, covering populations ranging
from one to twelve million people. See Judy Packer-Tursman, Organ-Sharing System: How Would It
Work?, PITTSBURGH POST-GAZETTE, July 21, 1999, at Al. Siegel describes the role of OPOs as fol-
lows:
Each OPO must participate in the OPTN. The Secretary of Health and Human Services
makes grants to OPOs to execute projects that increase the supply of donated organs. Each
OPO locates potential organ donors and arranges for the acquisition, preservation, and trans-
portation of the organs to transplant centers. The OPO must coordinate its activities with
transplant centers within its region. An OPO is also responsible for helping hospitals estab-
lish protocols for determining the organ donor status of its patients.
Siegel, supra note 23, at 935-36.
54 42 USCA § 273(b)(3)(B).
55 42 USCA § 273(b)(3)(e)-(f).
56 42 USCA § 273(b)(3)(k). Generally, the organ allocation system gives top priority to patients
who are close biological matches, since closer matching tends to result in better longterm survival after
transplantation. When possible, in order to minimize organ preservation time, organs are offered first to
patients locally, then regionally, then nationally. Waiting time is used to break ties between patients
who are similar in other respects. See UNOS Facts and Figures, at
http://www.unos.org/Resources/factsheets.asp?fs-5 (last visited April 5, 2005). More detailed donation
and distribution policies can be found at
http://www.unos.org/policiesandbylaws/policies.aspresources=true (last visited April 5, 2005). See
also Judy Packer-Tursman, Report: New Rule Won 't Make Liver Transplant Harder to Get,
PITTSBURGH POST-GAZETTE, Aug. 25, 1999, at A3. There has been concern though that the system is
inadequate to meet the needs of the sickest patients nationwide. See Daubert, supra note 50, at 469.
57 Finally, NOTA established other mechanisms for encouraging organ donation, including a Task
Force on Organ Transplantation. See National Organ Transplant Act, Title 1-Task Force on Organ
Transplantation, 42 U.S.C. § 273 (2000). As Siegel discusses, the Task Force was designed to examine
the problems relating to organ procurement and recommend potential solutions. See Siegel, supra note
23, at 936. She summarizes its conclusions and impact succinctly:
The Task Force's 1986 report determined that most families of potential donors were un-
aware of their option to donate, that OPOs varied in their ability to procure organs, and a
lack of uniformity decreased the OPTN's effectiveness. The Task Force recommended the
establishment of a national network to regulate organ acquisition and distribution. The Task
Force report suggested increasing public education and outreach, requiring hospitals to rou-
tinely ask the immediate family to consider organ donation, and allocating resources based
on objective criteria. In response, Congress included in the Omnibus Budget Reconciliation
Act of 1986 an amendment to the Social Security Act. This amendment mandated that all fa-
cilities engaging in organ procurement or transplant procedures become members of the
OPTN or else forfeit their participation in Medicare and Medicaid. UNOS, essentially, be-
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B. The Law's Unintended Consequence: Organ Scarcity
The large majority of Americans support NOTA's and UAGA's legal
framework providing for altruistic organ donations. A 1999 study showed
that 81% of Americans support the concept of voluntary organ donation.
5 8
However, Americans have yet to match their ideals with their actions, as
only about one-quarter have actually signed up as registered donors.
59
Compounding the problem is the fact that many health care professionals
are reluctant to ask family members for consent to harvest the organs of the
deceased, and many families refuse to give consent. 6° In the United States,
when potential donors61 are not registered as organ donors, only half of the
deceased's relatives consent to donation.62
Thus, despite NOTA's and UAGA's noble intention of encouraging
voluntary organ donation, shortages continue to worsen. Today's statistics
are downright alarming. Every 13 minutes, a new name is added to the
United States' National Organ Transplant Waiting List.63 On average, 17
came the regulator of the OPOs and hospitals, which conformed from fear of losing Medi-
care and Medicaid privileges.
Id. (internal citations omitted).
58 Pew Research Center for the People and the Press, supra note 10.
59 A 1993 poll indicated that just 28% of Americans have signed up as organ donors. The Gallup
Organization, Inc., supra note 10. Hansmann cites to a 1985 poll that showed that that only 17% of
Americans had completed organ donor cards. See Hansmann, supra note 9, at 60 n.9. A 1999 study
found that only 42% of Americans reported that they had actually signed an organ donor card. See Pew
Research Center for the People and the Press, supra note 10. The fact that Americans largely do not
back up their beliefs with actions has led some to question the amount of money spent on educating the
public regarding the need for voluntary organ donations, since these public awareness campaigns have
not been extremely successful in producing results. See John Jurgensen, Organ Donor Dilemma Plans
to Spur Donations Raise Ethical Questions, THE HARTFORD COURANT, Dec. 12, 2003, at D1 (stating
that the millions of dollars spent on public awareness has done little good); Conan, supra note 43
(claiming that advertising regarding organ donation has not been successful).
60 Orly Hazony, Increasing the Supply of Cadaver Organs for Transplantation: Recognizing that
the Real Problem is Psychological Not Legal, 3 HEALTH MATRIX 219, 231-39 (1993). The National
Kidney Foundation estimates that about 35% of potential donors never become donors because family
members refuse to give consent. See National Kidney Foundation, supra note 9. Ellen Sheehy and
colleagues estimated that the percentage of families who agree to donate when asked was 54%. Ellen
Sheehy et al., Estimating the Number of Potential Organ Donors in the United States, 349 NEW ENG. J.
MED. 667, 673, fig. 3 (2003).
61 Here, a "potential" donor signifies a person who is legally dead (i.e., has suffered brain death)
but who still has viable organs that would be suitable for transplantation if she or her family were to
consent.
62 Jurgensen, supra note 59. But cf Tabarrok, supra note 6 (finding that when families are in-
formed of their loved one's interest in donating, they usually assent to donation).
63 Living Legacy Registry, Register to Become an Organ or Tissue Donor, at
http://livinglegacyregistry.org/ (last visited April 5, 2005). The Living Legacy Registry was created by
GEO. MASON L. REV.
patients die every day while awaiting an organ-one person every 85 min-
utes.64 In 2003, 6,776 Americans died while awaiting an organ transplant,
according to official reports.65 7,227 died in 2002, and 7,178 died in 2001.6
The actual figures are in fact considerably higher-patients who are on the
waiting list but become too sick to undergo transplant surgery are taken off
the list and their eventual deaths are not recorded in official figures.6 7 In
addition, many people who could benefit from an organ transplant are never
put on the waiting list because the probability of obtaining an organ is too
low.
68
As of November 15, 2004, 87,310 Americans were candidates for an
organ.69 Of this number, 63,438 awaited a kidney, 3,366 a heart, 17,920 a
liver, and 3,972 a lung. 70 Conversely, the total number of organ transplants
performed in the U.S. in 2003 was just 25,468, of which 15,138 were kid-
neys (8,670 from cadavers, and 6,468 from living donors). 71 The disparity
between these numbers requires that patients often wait many years for an
organ to be found.72 The OPTN 2003 Annual Report bluntly states: "The
problem of long waiting times for transplant candidates and/or the contin-
ued growth in waiting list size underscores the simple reality: supply of
organs does not meet the need.,
73
This reality is depicted graphically below with the help of economic
analysis-a useful tool in illustrating the effect of NOTA and UAGA.
legislation passed in 2003 to help enable the public to make educated choices about donation, as well as
register their choice to donate. Id
64 See id.
65 See OPTN, National Data Reports, at http://www.optn.org/latestData/step2.asp (search cate-
gory "Waiting list removals, Removal reasons by year") (last visited Nov. 15, 2004).
66 See id.
67 See Tabarrok, supra note 6.
68 Id.
69 See UNOS, Data, at http://www.unos.org (last visited Nov. 15, 2004).
70 See OPTN, National Data, at http://www.optn.org/latestData/rptData.asp (search category
"Waiting List, Overall by Organ") (last visited Nov. 15, 2004).
71 See id. (search category "Transplant, Transplants by Donor Type") (last visited Nov. 15, 2004).
72 See id. (search category "Median Waiting Time"); see generally Susan Hankin Denise, Note,
Regulating the Sale of Human Organs, 71 VA. L. REV. 1015, 1019 (1985) (stating that waitlist times are
"often measured in years rather than months."); Phyllis Coleman, "Brother, Can You Spare a Liver?"
Five Ways to Increase Organ Donation, 31 VAL. U. L. REV. 1, 1-2 (1996) (discussing the issues in-
volved in average organ waiting times).
73 See U.S. DEP'T OF HEALTH & HUMAN SERVICES, 2003 ANNUAL REPORT OF THE U.S. ORGAN
PROCUREMENT AND TRANSPLANTATION NETWORK AND THE SCIENTIFIC REGISTRY OF TRANSPLANT
RECIPIENTS: TRANSPLANT D ATA 1993-2003, available at
http://www.ustransplant.org/p/ar?y-2003&p=chapter-i.ar-cd.htm,i (last visited April 5, 2005) (empha-
sis added).
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S' (constrained supply under NOTA & UAGA)
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£4,00allow sale




market price -- -- -- -- -- ---- - -- - - - -- -*- market clearing
$20,000 price & quantity
C
A
Y 7 D: DemandPrice = $0. for Kidneys
8,000 actually 12,000 would be Quantity of Kidneys
supplied at P40 supplied at P =$20K
When society bans organ sales, it is analogous to imposing a price
ceiling of $0 on human organs. 74 Even at this artificially suppressed price,
economists Pindyck and Rubinfeld note that 8,000 organs will still be sup-
plied, solely on the basis of the donor's altruism. 75 However, supply is con-
strained at that point, as no more organs can be induced into the market-
place through the incentive of payment. While 8,000 kidneys are supplied,
12,000 are actually demanded.76 If sales were legal, Pindyck and Rubinfeld
estimate that the market clearing price would be $20,000 77 -i.e., at a price
of $20,000, 4,000 more kidneys would be supplied, and 4,000 people cur-
rently on dialysis would be willing to purchase them. Because federal law
prohibits sales, however, these mutually beneficial trades never occur.78
Potential suppliers are forced to keep both of their kidneys even though
some would rather sell them, and those in need are forced to wait (and pos-
sibly perish while doing so) even though they would be more than willing
to buy a kidney if they could. Economists refer to the absence of these mu-
tually beneficial trades as "deadweight loss"-both buyers and sellers
would be better off without the law banning human organ sales, but for
other reasons we prevent the trade from occurring.79 The areas marked A +
C represent the loss to suppliers because they are not allowed to sell kid-
74 Price ceilings are the inverse of more commonly imposed price floors, the most widely used
example of which is the federal minimum wage.
75 See ROBERT S. PINDYCK & DANIEL L. RUBINFELD, MICROECONOMICs 292-94 (2d ed. 1992).
76 Id. at 292-93.
77 Id. The $20,000 figure was an estimate made in 1992; the market price for kidneys today would
likely be significantly higher.
78 Id. at 292.
79 Id. at 294.
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neys, while A - B equals the "gain" to recipients if kidneys are free. (Trian-
gle A represents the boon of free kidneys to those who actually receive
them, while B represents the people who need kidneys, could have and
would have purchased them under a market system, but are prohibited from
doing so under federal law.)8 ' The idea behind NOTA and UAGA is that
kidney recipients are given the "gift" of life, not one which they must pay
for.8' Of course, that idea holds true only for the 8,000 individuals who
were fortunate enough to actually find one; surely the other 4,000 who find
themselves in the deadweight loss triangle do not perceive current law to be
a "gift."
Thus, the law banning human organ sales has the unintended and un-
fortunate consequence of restricting supply below market clearing levels
and preventing mutually beneficial trades from occurring. As a result, over
6,000 people die each year, but still, this tragic outcome may be justified on
the basis of morality, distributive justice, or externality concerns if we were
to allow organ sales instead. 2 Many individuals believe that it would be
immoral to commodify the human body, that any "informed consent" to
sale would be based solely on the temptation of a cash reward, that negative
externalities would fall on society to care for sellers whose health later de-
teriorated, and that the distributive consequences of allowing sales would
be perverse (i.e., the poor would be exploited into selling their organs, and
only the wealthy would have access to those organs supplied). All of these
concerns will be addressed in Parts II and III.
C. The Thriving Global Black Market: A Recipe for Abuse and Exploita-
tion
As a result of the legal and public policy decision to ban organ sales in
the U.S., not only is there a serious disparity between organ demand and
supply, but a thriving global black marketplace ripe for abuse and exploita-
tion as well.
It is illegal in nearly all developed nations to sell or buy a human or-
gan-only in Iran and Pakistan is there a legal market.83 Nevertheless,
80 Regions A + D represent the total value of kidneys when supply is constrained. One should note
that the total value under artificial supply constraints due to NOTA and UAGA is less than the total
value were a free marketplace permitted (which would encompass A + D + B + C).
81 See PINDYCK & RUBINFELD, supra note 75, at 294.
82 See infra Part II.
83 See Vidya Ram, International Traffic in Human Organs, 19 FRONTLINE, Issue 7, Mar. 30 - Apr.
12, 2002, at 61, available at http://www.flonnet.com/fll907/19070730.htm (last visited April 5, 2005);
Eddie Fitzmaurice, Rich Developer Pays Poor Pakistani $8000 for One of Her Kidneys, SUN HERALD
(SYDNEY), Mar. 30, 2003, at 76, available at 2003 WL 7332302.
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many other countries, including Israel, India, South Africa, Turkey, China,
Russia, Iraq, Argentina, and Brazil do not stringently enforce laws prohib-
iting the sale and purchase of human organs. 84 Moreover, given the literally
life-or-death consequences, many patients, doctors and organ brokers are
not deterred in the least by the illegality of cash transactions in human or-
gans.
As a result, a global black market in human organs and a booming
transplant tourism industry has emerged. 85 The severe organ shortage in the
United States has led many dialysis patients to become reluctant partici-
pants, as they purchase organs abroad, usually from downtrodden sellers
seeking to escape the poverty of their homeland.86 In fact, three hundred
Americans travel abroad each year to buy a human organ, usually kid-
neys.87 The trade is not limited to Americans with means, as thousands of
persons from developed nations who await transplants have decided to
travel to countries where purchase of human organs is legal or where bans
are not strictly enforced. A wealthy Englishman, Thor Andersen, sparked
debate over the ethics of this practice when he became the first major figure
to publicly admit to being a transplant tourist.88 He traveled to Pakistan to
legally purchase a kidney from a poor 22-year-old Pakistani villager.89 An-
dersen was not deterred by the perceived immorality of the transaction, and
reportedly expected his private health insurance provider to reimburse him
for the costs of his trip and surgery. 9 He argued that he did nothing illegal
and that his health care costs were less than what they would have been had
he continued dialysis treatments. In other words, he claims that it is cost-
effective and welfare-maximizing to buy organs for transplant. 91
84 See Marina Jimenez, Europe's Poorest Sell Their Kidneys, NATIONAL POST, Mar. 29, 2002, at
AI, available at 2002 WL 17680080; Michael Finkel, Complications, N.Y. TIMES, May 27, 2001, at
F26; O'Neill, supra note 7; Jeremy Laurance, Surgeons Call for Legislated Trade in Body Parts, THE
INDEPENDENT-LONDON, Apr. 9, 2002, at 10.
85 See Robyn S. Shapiro, Legal Issues in Payment of Living Donors for Solid Organs, HUMAN
RIGHTS MAGAZINE, Spring 2003, at 19; Joanna Geary, Illegal Live Organ Surgery Reopens Donor
Debate, BIRMINGHAM POST, Sept. 24, 2003, at 2; Ram, supra note 83.
86 See Mann Aiyappa, Kidney Racket-Many Questions Unanswered, THE TIMES OF INDIA, Jan.
19, 2002 (discussing the fact that poor sellers are themselves often from different countries and are lured
by organ brokers into the transaction.) See Marina Jimenez, 'Doctor Vulture': At the Center ofIstan-
bul's Illicit Kidney Trade is a Shadowy 44-Year-Old Surgeon Whose Transplant 'Donors' Are Not
Always Willing Ones, NATIONAL POST, Mar. 30, 2002, at B02, available at 2002 WL 17680437.
87 See O'Neill, supra note 7.
88 See Fitzmaurice, supra note 83; Tessa Mayes, Tycoon Buys Pakistan Girl's Kidney, SUNDAY
TIMES (LONDON), Mar. 23, 2003, at 13.
89 See Fitzmaurice, supra note 83.
90 See id.
91 See id. Dialysis costs approximately $50,000 per year, making it far more expensive than a one-
time transplant. TransWeb.org, What Are the Real Costs of Transplants?, a t
2004]
GEO. MASON L. REV.
In nations where sales are nominally illegal, the black market has not
been much deterred. Kidney sales were banned in India in 1994, but pa-
tients continue to capitalize on kidney brokers (often working on behalf of
Indian hospitals) to locate seller-donors. 92 To circumvent the law, donors
simply sign an affidavit swearing they are not being paid.93 In 2001, it was
estimated that nearly $10 million dollars had exchanged hands for 4,000
transplants in Bombay alone.94 Lax medical standards have made prosecu-
tion extremely difficult, leading India to become known as the world's
"warehouse for kidneys." 95 In addition, despite a ban on sales, Iraq pos-
sessed one of world's best black marketplaces for human organs prior to
America's invasion in 2003.96 One Palestinian family boasted three chil-
dren who had received successful illegal kidney transplants in Baghdad.97
The inability to effectively prosecute these transactions is not unique
to Asian and Middle Eastern nations. In Estonia, a group of Israeli doctors
were caught illegally transplanting organs, but the case was not pursued by
authorities.98 One Austrian, who offered his kidney for sale, was recently
convicted in a German court and handed a 2000 euro fine and four-month
suspended sentence-a sanction that would hardly seem to deter desperate
patients who willingly pay tens of thousands of dollars for life-saving or-
gans.99
Illegal organ transplants take place even in America. There is no na-
tional transplant screening board in the United States; each hospital sets its
own rules for who can be a live organ donor.' ° Foreign patients often ar-
rive with a willing, unrelated "donor" and money in hand. l°' Some U.S.
hospitals have a "don't ask, don't tell" policy with respect to foreigner or-
gan transplants, 10 2 and organ brokers know how to find these hospitals. To
http://www.transweb.org/qa/asktw/answers/answers9505/TherealcostsofTransplants.html (last visited
Oct. 25, 2004) (posting of Phillip J. Held, M.D.).
92 See John Ungoed-Thomas and David Orr, GPs Offer Kidneys from Living Third World Donors,
SUNDAY TIMES (LONDON), Apr. 1, 2001, available at LEXIS, News Library, Times.file.
93 Id.
94 O'Neill, supra note 7.
95 Id.
96 See Finkel, supra note 84. Iraq's black market is likely no longer thriving after the U.S. led
invasion of the country in 2003.
97 Id.
98 O'Neill, supra note 7.
99 Austrian Who Offered Kidney for Sale On Internet Is Convicted, AUSTRIA TODAY, July 14,
2003, available at 2003 WL 59216100.
100 See Finkel, supra note 84.
101 See id.
102 See id.; Your Money or Your Life: The Kidney Trade, CBSNEWS.COM July 31, 2002, at
http://www.cbsnews.com/stories/2002/02/11/48hours/main328962.shtml (last visited April 5, 2005)
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avoid strict federal regulations banning sales, the foreign donors and recipi-
ents merely pretend to be related.l13 As recently as 2001, dozens of Molda-
vians were suspected of seeking to enter the U.S. to illegally sell their kid-
neys.1 4 Clearly, the black market is not merely a problem outside of
American borders.
Worse, the lack of a legally regulated organ marketplace or effective
organ donation policy in the U.S. has resulted in gross exploitation of the
poor elsewhere in the world.l15 Sellers in illegal markets are usually facing
desperate situations, and are often unemployed and dealing with serious
health problems of their own. 10 6 This combination of factors makes them
easy targets for unscrupulous organ brokers and doctors who answer to no
legal authority. Human rights abuses are commonplace, as even prisoners
and homeless people are exploited for the benefit of unscrupulous actors.1
0 7
(citing to Dr. Michael Friedlander).
103 See id
104 See Jimenez, supra note 84.
105 See Christian Williams, Combatting the Problems of Human Rights Abuses and Inadequate
Organ Supply Through Presumed Donative Consent, 26 CASE W. RES. J. INT'L L. 315, 315-16, 344-46
(1994).
106 Your Money or Your Life, supra note 102 (quoting Nancy Scheper-Hughes, director of Organs
Watch, an international group that monitors the sale of human organs and the people who sell them).
107 O'Neill, supra note 7. For example, reports have surfaced that homeless persons in Argentina
and South Africa have been murdered for their organs. Id. Doctors in those countries loosely define
brain death in order to meet their quota of organs for the military hospitals who, in turn, transplant them
to patients in the ruling class. Id. There have even been accusations that homeless persons are given
drugs to induce symptoms of brain death and that their organs are then removed. Id; Williams, supra
note 105, at 316.
Even when organs are harvested from cadavers instead of living human beings, the potential for
abuse of the deceased and their families remains. The Chinese lead the world in selling organs from
criminals' cadavers to patients from countries including Taiwan, France, Indonesia, the United States,
and Great Britain. See O'Neill, supra note 7. Not coincidentally, China also leads the world in execu-
tions, as the death penalty is employed for crimes that the rest of the world would consider relatively
minor, including petty theft and tax evasion. Cf John Schauble, Crime Clamp Puts China at the Top of
the Execution List, THE AGE, Apr. 11, 2002, at 1I. This indiscriminate use of capital punishment has led
Amnesty International officials to speculate that the ability to illegally sell human organs is an incentive
for Chinese authorities to kill prisoners. See Steven Dennis, M 7,000 Kidney From Convict On Death
Row: Mike Pays For Organ From China, MIRROR, Jan. 11, 2001, at 17. In fact, one doctor claimed he
witnessed a prisoner's organs being harvested while he was still breathing. See Miriam Donohoe, Organ
Harvesting Claims Denied. Beiing Says Claims of Taking Organs From the Executed are Lies, The
Irish Times, July 5, 2001, at 12. Additionally, the rights of the family of the deceased are commonly
violated, as prisoners' organs are often sold regardless of their family's consent. Id. Since remains are
cremated, families often do not know what happened to the organs of their loved ones. Id.
Finally, despite this potential for abuse, some have suggested prisoner organ donation as a
partial solution to America's organ shortage. In fact, Missouri legislators proposed a bill that would
commute the sentences of death row inmates to life in prison if they agreed to donate an organ to some-
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In fact, a landmark 2002 study of illegal kidney sales in India revealed
that of the 305 sellers surveyed, 96% sold a kidney in an effort to escape
debt. °8 Unfortunately, given the absence of legal oversight, those individu-
als were paid on average one-third less than that which they were prom-
ised.'19 Further, after selling a kidney, family income declined, the donors'
debt burden did not ease, and 86% reported that their health worsened sig-
nificantly. 10 Some argue that the illegality of the transaction itself may
cause some of the problems experienced by these donors-they are typi-
cally afraid to seek post-operative care and are given no psychological
counseling to deal with the ramifications of their choice."'
Thus, despite the developed world's noble intention to ensure that or-
gan donations truly represent the gift of life for recipients, severe organ
shortages have ensued, leading to thousands of needless deaths as well as a
thriving global black marketplace that exploits its participants. In response,
one in need. See Kim Bell, Bill Would Let Inmates Barter Their Organs, ST. LOUIS POST-DISPATCH,
Feb. 6, 1998, at C3. The topic is quite controversial, as one must reasonably query whether a death row
prisoner can exercise his informed consent in the same way as an individual whose freedom has not
been deprived by his prior actions. See Mark F. Anderson, The Prisoner as Organ Donor, 50 SYRACUSE
L. REv. 951, 956 (2000) (finding the existing prisoner donation proposals wanting, and offering an
alternative that would allow prisoners not on death row to donate their organs to prisoners in need);
Whitney Hinkle, Giving Until It Hurts: Prisoners are Not the Answer to the National Organ Shortage,
35 IND. L. REv. 593, 610-12 (2002); Laura-Hill M. Patton, A Call for Common Sense: Organ Donation
and the Executed Prisoner, 3 VA. J. SOC. POL'Y & L. 387, 415-16 (1996). Thus, given the rampant
human rights abuses that plague prisoner populations across the world, we should think twice before
opening up inmates to another potential avenue of exploitation. As a practical note, organ donation by
prisoners in the U.S. is rarely permitted. See Anderson, supra at 957 n.20.
108 Madhav Goyal et al., Economic and Health Consequences of Selling a Kidney in India, 288 J.
AMER. MED. ASSOc. 1589, 1591 (2002). Debt included food and household expenses, rent, marriage,
and medical costs. Id.
109 See id.
110 Seeid.
Ill Lyndsay S. Baines and Rahul M. Jindal, Letters, Consequences of Selling a Kidney in India,
289 J. AMER. MED. ASSOC. 697 (2003). Baines and Jindal argue that the hostility and anger of Indian
sellers may be a product of the caste system and may result from lack of psychological support. Id
While Goyal's study emphasized that the health of donors deteriorated, Baines and Jindal posit that this
may have also occurred in the absence of any organ sale due to underlying poverty. Id. Further, the
illegality of organ sales themselves may cause post-operative care to be of low quality. Amitabh
Chandra, Letters, Consequences of Selling a Kidney in India, 289 J. AMER. MED. ASSOC. 697, 697
(2003). In addition, some survey respondents may have downplayed financial outcomes (including
remuneration received) to avoid incriminating themselves. Prem K.G. Chandran, Letters, Consequences
of Selling a Kidney in India, 289 J. AMER. MED. ASSOC. 697, 698 (2003). Finally, educated sellers
might experience more positive outcomes because they are better able to capitalize on immediate eco-
nomic gain, and studies have shown that the health of Western donors does not substantially worsen
after kidney donation. S.S.M. Razvi, Letters, Consequences of Selling a Kidney in India, 289 J. AMER.
MED. AssOc. 697, 698 (2003).
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several commentators have recommended that some form of legalized hu-
man organ sales be permitted. To date, none of these proposals have been
acted upon in any substantial manner by public policy decisionmakers.
Furthermore, critics have assailed legalized organ sales on multiple
grounds, decrying the immorality of commodifying the human body, ques-
tioning the distributive impact on the poor, and lamenting the potential
negative consequences for society.
II. TRADITIONAL ARGUMENTS AGAINST LEGALIZING HUMAN ORGAN
SALES
The government has a number of legitimate interests in banning hu-
man organ sales. Concerns regarding morality, distributive justice, imper-
fect information and negative externalities have persuaded public policy
decisionmakers that the risks of legalized markets are too great to justify
their benefits.
A. Morality: It Is Inappropriate to Commodify the Human Body
At the heart of NOTA's ban on human organ sales is a fundamental
concern that the dignity of man would be debased if life, health or body
parts were exchanged across a market." 2 One will often hear people say,
"Only God determines when to give or take life"-it should not be deter-
mined by dollars." 3 Courts and legislatures have long argued that the sanc-
tity of the body is essential to human dignity and autonomy. 14 Drawing
112 Daubert, supra note 50, at 466. As Gail Daubert describes, "Congress decided that proposals
for buying and selling organs ran counter to society's ethical and moral values and thus refused to allow
human organs to be commodified. Id. Congress rejected what it deemed "supply-side cannibalism" as a
means of increasing the number of organs available for transplant, claiming it did not want to make the
'poor a source of spare parts for the rich."' Id.; see also id. at 466 n.43 (citing to Procurement & Allo-
cation of Human Organs for Transplantation, 1983: Before the Subcommittee on Investigation & Over-
sight of the House Committee on Science & Technology, 98th Cong. (1983), reprinted in National
Organ Transplant Act of 1984, Legislative History of Pub. L. No. 98-507, Vol. 2 (1990), at 307-18, 218,
248) (quoting then-Congressman Albert Gore, Jr., chairman of subcommittee, who stated that the sale of
organs "blurs the distinction between people and things, as human organs become simply another com-
modity to be bought and sold in the marketplace").
113 Telephone interview with Alyse Merritt, marketing representative for Momingstarlnterac-
tive.com (July 1, 2004). Relatedly, some physicians believe it would undermine the integrity of the
medical profession to become involved in legalized human organ markets-i.e., doctors should be
healers, not facilitators of a trade in human body parts. See, e.g., Johnson, supra note 44, at 749 (fram-
ing this concern as more of a legislative one than that of a physician's).
114 Melissa M. Perry, Fragmented Bodies, Legal Privilege, and Commodification in Science and
Medicine, 51 ME. L. REV. 169, 174, 183-97 (1999) (discussing courts' and legislatures' use of the
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heavily on the wisdom of renowned philosopher Emanuel Kant, Stephen
Munzer similarly urges that it would offend human dignity to allow unre-
stricted market transactions in organs." 5 The overarching fear is that the
human body should not be treated as a commodity to be bought and
sold' 16 -doing so would have a dangerous and dehumanizing impact on
society."' When organs are donated to prevent another human being's
death, this represents the ultimate altruistic "gift" of life, one which has no
monetary strings attached.118
Furthermore, a strong belief in inalienable rights justifies the prohibi-
tion on sales of body parts.119 While libertarians argue that a person should
argument that the sanctity of the body is essential to human dignity and autonomy, but noting that it
comes at the expense of science's "entrepreneurial interest" in its subjects).
115 Stephen R. Munzer, An Uneasy Case Against Property Rights in Body Parts, I SOC. PHIL. &
POL'Y 259 (1994); Stephen R. Munzer, Kant and Property Rights in Body Parts, 6 CAN. J.L. & JURIS.
319, 320 (1993); cf Mark F. Grady, Politization of Commodities: The Case of Cadaveric Organs, 20 J.
CORP. L. 51, 56-58 (1995) (exploring Munzer's argument and arguing for a limited form of human
organ sales to be permitted).
116 The legislative history states succinctly: "It is the sense of the [Senate Labor and Human Re-
sources] committee that individuals or organizations should not profit by the sale of human organs for
transplantation .... The committee believes that human body parts should not be viewed as commodi-
ties." See S. Rep. No. 98-382 (1984), at 16-17, reprinted in 1984 U.S.C.C.A.N. 3975, 3982-83.
117 See Finkel, supra note 84 (stating that treating humans as commodities is a throwback to the
days of slavery). See also Johnson, supra note 44, at 750-51 (discussing the fear of the dehumanizing
impact on society if organ sales were permitted); MARGARET JANE RADIN, Contested Commodities, in
HUMAN FLOURISHING AND LIMITS ON MARKETS 125-26 (Harv. Univ. Press 1996).
118 Consistent with the notion that donation should be seen as the ultimate act of generosity, there
is concern that some individuals who today donate out of purely altruistic motivation would be deterred
from doing so by an explicit marketplace in organs. In fact, according to a 1993 Gallup Poll, over 80%
of Americans said they would not be spurred by monetary incentives to donate organs, and 5% indicated
they would be even less likely to donate than they are today if money were offered. See The Gallup
Organization, Inc., The American Public's Attitudes Toward Organ Donation and Transplantation 43
(Feb. 1993), available at http://www.transweb.org/reference/articles/gallupsurvey/gallup chap7.html
(last visited Nov. 5, 2004). Adam Kolber notes that since pollsters did not mention the size of the finan-
cial incentives at stake, we should not be overly reliant on responses to this question. Adam J. Kolber, A
Matter of Priority: Transplanting Organs Preferentially to Registered Donors, 55 RUTGERS L. REV.
671 (2003); see also Mark F. Anderson, The Future of Organ Transplantation: From Where Will New
Donors Come, to Whom Will Their Organs Go?, 5 HEALTH MATRIX 249, 299-301 (1995) (allowing
payment of any kind cheapens the act and threatens the integrity of the entire system); Frank Morgan,
Babe the Magnificent Organ Donor? The Perils and Promises Surrounding Xenotransplantation, 14 J.
CONTEMP. HEALTH L. & POL'Y 127, 134 (1997) (altruistic donations may be curtailed by legalized
market system).
119 See, e.g., Conan, supra note 43 (noting that no one possesses total ownership over their own
bodies; for instance, one cannot legally opt to become a slave or a prostitute even if she is willing). See
also Susan Rose Ackerman, Inalienability and the Theory of Property Rights, 85 COLUM. L. REV. 931
(1985); Margaret Jane Radin, Market Inalienability, 100 HARV. L. REV. 1849 (1987). However, many
commentators have argued vociferously for an alienable property right to one's organs. See, e.g., Wil-
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be free to do as she wishes with her own body, this view has been widely
rejected under prevailing law and morality. Drug use, prostitution, bigamy
and incest are all legally banned-in large part due to the moral objections
of nonparticipants. Less controversially, mandatory seatbelt or helmet laws
restrict a person's ability to do what she wishes or to take certain risks with
her own body, even if she values this freedom more than society values the
need to provide for public safety. Indeed, there are myriad examples in law
where individual autonomy gives way to the state's morality interest.12° The
ban on human organ sales is one such case.
B. Distributive Justice
Related to Americans' moral aversion to human organ sales is the fear
that such transactions, if legal, would have a perverse distributive impact.121
If organs were allowed to be sold, it is reasonable to expect that dispropor-
tionately poor people, often minorities, would be persuaded or exploited
into selling their kidneys simply to escape debt. 122 Conversely, it would
primarily be the wealthy who could afford to purchase them. 123 Thus, ban-
ning human organ sales could be justified on distributive justice grounds:
the law would prevent poor people from becoming the only "sellers," and it
would provide both poor and wealthy individuals equal access to those or-
gans being supplied-regardless of their ability to pay.
124
liam Boulier, Sperm, Spleens, and Other Valuables: The Need to Recognize Property Rights in Human
Body Parts, 23 HOFSTRA L. REV. 693, 715-30 (1995); Brian Hannemann, Body Parts and Property
Rights: A New Commodity for the 1990s, 22 Sw. U. L. REV. 399, 426-28 (1993); Roger D. Blair and
David L. Kaserman, The Economics and Ethics ofAlternative Cadaveric Organ Procurement Policies,
8 YALE J. ON REG. 403, 435-39 (1991).
120 See, e.g., Guido Calabresi and A. Douglas Melamed, Property Rules, Liability Rules, and
Inalienability: One View of the Cathedral, 85 HARV. L. REv. 1089, 1102-05 (1972); Calabresi, supra
note 24, at 2132-51 (discussing the issue of whether we own our own bodies, or whether they belong at
least in some instances to those who need them). See also Jacqueline Laing, In Debt? Want to Flog One
of Your Kidneys? No, This Isn't a Joke. With Staggering Amorality Our Medical Elite Now Think It's
OK for Us to Sell Our Body Organs, DAILY MAIL, Dec. 4, 2003, at 12.
121 Williams, supra note 105, at 316 (stating that "[o]ften, it is the poorer citizens of developing
countries who are supplying organs for the members of the upper class who can afford them").
122 Id.
123 See Kidneys Sold Here!, THE HINDU, Feb. 24, 2002. But cf Thomas Sowell, The High Cost of
Busybodies, TOWNHALL.C 0 M , Dec. 2, 2003,
http://www.townhall.com/columnists/thomassowell/ts2003l202.shtml (last visited April 5, 2005) (stat-
ing that society's ban on organ sales does not alleviate the problem of poverty, and that purchasers of
organs in a market system would not necessarily have to be rich).
124 In fact, the U.S. Department of Health and Human Services Advisory Committee on Organ
Transplantation justified the ban on selling organs in this manner, stating that Congress was concerned
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The potential for exploitation is not merely a theoretical or academic
concern. 125 Newspaper and medical journal accounts of black markets in
organs document the fact that poverty is the driving force behind sales.' 26 A
recent study in the Journal of the American Medical Association confirmed
that 96% of black market kidney sellers in India agreed to the sale in an
effort to escape financial hardship.127 Worse, the great majority of sellers
found themselves in continued debt six years later, accompanied now by
deteriorated health. 128 On the opposite side of the spectrum, it is predomi-
nantly the wealthy of society who can afford to make organ pur-
chases-after all, one can only pay a large sum of money to save her own
life if she has the financial means to do SO.
129
Thus, where the poorer classes of society are exploited by markets
in human organs, and where primarily the upper classes have access to the
product, critics are justified in highlighting the distributive inequity of such
an outcome.
C. Lack of Information About Risk
Another legitimate concern posed by allowing a market for human or-
gans is that sellers would lack sufficient information to properly weigh the
consequences on themselves and society when they make the choice to
trade their organs for cash.13 ° Sellers might simply not know of the added
that "buying and selling of organs might lead to inequitable access to donor organs with the wealthy
having an unfair advantage." U.S. DEP'T OF HEALTH & HUMAN SERVICES, ADVISORY COMMITTEE ON
ORGAN TRANSPLANTATION, FREQUENTLY A SKED QUESTIONS, a I
http://www.organdonor.gov/faq.html#l I (last visited April 5, 2005).
125 See John Lawrence Hill, Exploitation, 79 CORNELL L. REV. 631, 644-47 (1994) (proposing a
theory of exploitation in three areas of legal controversy, including the voluntary sale of organs by
living donors).
126 See Kidneys Sold Here!, supra note 123 (detailing the illegal organ trade in India, and its rami-
fications for the poor); They Made a Small Fortune, But Were Poorer by a Kidney, THE HINDU, Jan. 19,
2002 (finding that most sellers in an Indian village were of the labor class and in financial crisis);
Rohter, supra note 2 (recounting the tale of a poor Brazilian son of a prostitute who sold his kidney in
an effort to improve the conditions in which he was living).
127 Goyal et al., supra note 108, at 1591. The average amount received was $1,070, although the
average amount promised was $1,410. Id.
128 Id. at 1589, 1591 (71% of sellers continued to find themselves below the poverty line); see also
They Made a Small Fortune, But Were Poorer by a Kidney, supra note 126 (finding that donor health
deteriorated after organ sales).
129 Kidneys Sold Here, supra note 123. But cf Sowell, supra note 123.
130 See PINDYCK & RUBINFELD, supra note 75, at 294 (citing imperfect information as a possible
justification for banning organ sales).
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health risks that they are taking when they agree to sell a kidney,'31 think-
ing that one kidney is just as good as two. Further, the temptation of a one-
time lump sum payment to escape debt might lead some poverty stricken
individuals to think that selling a kidney is worth any health risk entailed.'32
Compounding this problem is that potential sellers often suffer from "opti-
mism bias"-i.e., even if they understand the precise risks involved, they
often believe that those risks simply "won't happen to me.', 133 Furthermore,
sellers might impose unknown risk on buyers by concealing adverse health
information in their own past so as not to be ruled out as a potential candi-
date for sale.134 Thus, if sellers are pressured by poverty and simultaneously
underestimate the risks that organ sales involve or overestimate their ability
to escape them, society's confidence in their informed consent to the sale is
seriously undermined. 135 The state therefore has a legitimate interest in
stepping in to protect the mental and physical health of potential sellers
against risks that they do not fully appreciate. 136
In fact, data from today's black market reinforces this conclusion. Of
the sellers in India's black market kidney trade, 86% reported that their
health had deteriorated substantially from its pre-sale condition. 137 Not sur-
prisingly, given the wisdom of hindsight, four out of five sellers would not
131 For instance, potential risks include perioperative mortality and renal dysfunction in the kidney
donor. G. Splendiani, Living Donor Transplant: Wider Selection Criteria, 36 TRANSPLANT PROC. 470
(2004). There are at least sixteen documented cases of individuals who have died from donating a
kidney. Procurement and Allocation of Human Organs for Transplantation: Hearings on H.R. 5580
Before the Subcomm. on Investigations and Oversight of the House Comm. on Science and Technology,
98th Cong. 269 (1984) (testimony of Oscar Salvatierra, President of the American Society of Transplant
Surgeons).
132 See Sullivan, supra note 12 (noting that the temptation of a cash reward for selling one's kidney
makes a mockery of traditional notions of informed consent).
133 See generally Neil D. Weinstein, Why it Won't Happen to Me: Perceptions of Risk Factors and
Illness Susceptibility, 3 HEALTH PSYCHOL. 431 (1984); Neil D. Weinstein, Unrealistic Optimism About
Susceptibility to Health Problems: Conclusions From a Community-Wide Sample, 10 J. BEHAV. MED.
481 (1987); Neil D. Weinstein, Unrealistic Optimism About Susceptibility To Health Problems, 5 J.
BEHAV. MED. 441 (1982).
134 See PINDYCK & RUBINFELD, supra note 75, at 294. Thus, one could hypothesize that the quality
of transplant organs could potentially decline in a for-sale regime. But cf Stephen J. Spurr, The Pro-
posed Market for Human Organs, 18 J. HEALTH POL., POL'Y & L. 189, 198 (1993) (arguing that al-
lowing organ sales will promote quality of sold organs due to competition in the marketplace).
135 See Sullivan, supra note 12.
136 See Johnson, supra note 44 (detailing the various governmental interests in banning human
organ sales).
137 Goyal et al., supra note 108, at 1591, Table 3; see also Finkel, supra note 84. Finkel notes that
organ donation may not be as safe as some argue because the studies showing a low risk of adverse
events have been conducted only in wealthy nations. Id. By comparison, donors with poor diet and bad
drinking water have a higher risk of infection that could compromise their remaining kidney, leading to
short-term complications in approximately 20% of extractions. Id.
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recommend that others follow their lead in selling organs. 138 Sadly, once a
sale occurs, the risk to the health of the individual is irreversible. Future
medical care expenditures are often required, and dialysis may be necessary
in the event that the remaining kidney fails. 139 These costs will fall first on
organ sellers and their families, but will also pose a burden to society
should the seller be unable to recover or unable to pay.
D. Negative Externalities Borne by Society
While health deterioration borne by a human organ seller may fall on
her own shoulders, the medical costs she cannot bear-plus her lost pro-
ductivity to society-present the classic "negative externality" imposed on
society. Economists define negative externalities as costs or harms that an
individual person or entity creates but which are borne by someone else (in
this case, the state). 140 Thus, the private calculus in agreeing to a sale (i.e.,
the amount of money received versus the predicted risks to the seller's
health) may be substantially different than the overall considerations facing
society. Because sellers may lack information or overestimate their resil-
iency, the state can be expected to bear significant medical costs to care for
some of those individuals in the future-costs that sellers will ignore in
making their own decision because they do not bear them.14
In response, the state might reasonably ban organ sales entirely to pre-
vent negative externalities from materializing in the first place. By doing
so, the state overrides an individual's preference so that it can protect the
overall public interest.
138 Goyal et al., supra note 108, at 1591. While Goyal's results paint a gloomy picture of organ
sales, commentators have argued in response that other reasons explain the largely negative results in
India. See Baines and Jindal, supra note I11.
139 While many studies have concluded that organ donation by living donors entails a low risk of
adverse events, those studies are generally of wealthy populations where sanitation and access to fol-
low-up health care are quite good. By contrast, in countries in which individuals maintain poor diets and
have access to lower quality drinking water, the risk of infection to the remaining kidney may be sub-
stantially higher. See Finkel, supra note 84.
140 EDWARD M. GRAMLICH, A GUIDE TO BENEFIT-COST ANALYSIS 18-20 (2d ed. 1990) (discuss-
ing externalities as a basis for government intervention in the private marketplace).
141 One should note, however, that the negative externality argument applies equally to those who
donate organs as well as to those who sell them.
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III. ARE THE TRADITIONAL ARGUMENTS AGAINST SALES COMPELLING?
While the arguments raised above highlight legitimate concerns sur-
rounding organ sales and their potential for abuse, a closer inspection limits
their force and offers opportunities for a thoughtful regulated response.
A. The Law Against Commodification of the Human Body Is Self-
Contradictory
To the extent that society subscribes to the belief that commerce in
human body parts is immoral and diminishes human dignity, we must
question how this justification conforms to other practices that we feel no
such qualms about allowing. For instance, how can one reconcile the notion
that human organs cannot and should not be sold with the reality that there
is a thriving market in the sale of human tissues and products? 142 Most no-
tably, sperm and ova banks prosper as Americans seek to remedy infertility
problems, and often charge customers thousands of dollars for their serv-
ices. 143 One potential response may be that unlike human organs, human
tissues and body products are regenerative; thus, selling them is a less dire
decision than parting with an organ. 144 However, the commodification ar-
gument has nothing to do with the relative sacrifice of the donor, only that
the product being sold is part of a human being, and that the dignity of man
142 The Senate Labor and Human Resources Committee distinguished between banning the sale of
organs versus allowing blood products because the latter are regenerative and do not pose a threat to the
donor's health. See S. Rep. No. 98-382, at 16 (1984), reprinted in 1984 U.S.C.C.A.N. at 3982; cf Don-
ald Joralemon & Phil Cox, Body Values: The Case Against Compensating for Transplant Organs,
HASTINGS CENTER REP. 27 (2003) (arguing against financial remuneration to organ sellers, but also
noting that the argument in favor of compensation for organs is no different from other permissible
forms of body commodification). For a detailed discussion of the law regarding the sale of human body
products and parts, see William Boulier, Sperm, Spleens, and Other Valuables: The Need to Recognize
Property Rights in Human Body Parts, 23 HOFSTRA L. REV. 693 (1995).
143 See, e.g., UCSF Center for Reproductive Health, at http://www.ucsfivf.org/ (last visited April 5,
2005) (detailing various infertility programs); California Cryobank Sperm Bank, at
http://www.cryobank.com/ (last visited April 5, 2005). A recent law article even tackled the idea that
lactating women might be given financial compensation for selling their breast milk. See Sarah E.
Waldeck, Encouraging a Market in Human Milk, II COLUM. J. GENDER & L. 361 (2002).
144 U.S. CONGRESS, OFFICE OF TECH. ASSESSMENT, NEW DEVELOPMENTS IN BIOTECHNOLOGY:
OWNERSHIP OF HUMAN TISSUES AND CELLS-SPECIAL REPORT 3 (1987), available at
http://www.wws.princeton.edu/cgi-bin/ byteserv.prl/-ota/disk2/1987/8719/871903.PDF (last visited
April 5, 2005) (stating that "[h]ealthy people continually produce a variety of replenishable substances,
including blood, skin, bone marrow, hair, urine, perspiration, saliva, milk, semen, and tears.") For
example, the ovaries contain nearly 400,000 ova, a number far in excess of what women actually need,
since during an average lifespan a woman goes through about 500 menstrual cycles. The Sex Project, at
http://www.sex-project.com/female-anatomy.shtml (last visited Oct. 25, 2004).
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is debased by allowing contact with the market. Thus, the objection to al-
lowing commerce for life-sustaining organs would apply equally to banning
the sale of human tissues or products that allow for life in the first in-
stance. 
145
Further, the notion that it is immoral to pay money to preserve one's
health or life directly conflicts with the reality of medical practice and pol-
icy in our country. If we believed as a moral matter that money should
never be exchanged for the preservation of life, why do we so readily ac-
cept the practice of charging fees for the provision of medical services at
all? Politicians often speak of health care as a "fundamental right" to be
provided to all regardless of their means,'16 but the reality indicates other-
wise. When a patient visits her physician in need of an antibiotic to cure her
life-threatening pneumonia, she is no less relieved of her obligation to pay
than if she were visiting a grocery store and trying to purchase milk. 147 The
truth is that individuals are forced to pay for health care if they want to re-
ceive it, and access to the system is far from guaranteed.
So, there are two stark choices that our country faces: (1) either com-
modifying the human body is morally inappropriate, in which case the
145 A related issue to the moral argument opposing organ sales is the question of how one would go
about measuring the extent of negative moral externalities that would be created by legalizing sales. We
could use a form of contingent valuation (heavily debated in the context of measuring damage from
environmental harms) under which people were simply asked how much they would be willing to pay in
order to live in a society that refused to allow organ sales. A problem with using such contingent valua-
tion surveys is that they often produce results that stretch the reasonable bounds of imagination. See
Note, "Ask a Silly Question... ": Contingent Valuation of Natural Resource Damages, 105 HARV. L.
REV. 1981, 1984-87 (1992). Further, a person's willingness to pay to receive the benefit of a certain
legal rule is often far lower than the amount that they would be willing to accept to give up the same
right if they were entitled to it from the outset (as a psychological matter, losing something you already
have is worse than gaining something new). Thus, the moral aversion to allowing organ sales would be
very difficult to measure in economic terms, but it represents a real cost. Even so, using an economic
mindset to attempt to include and measure the tradeoff is a more systematic way of considering the issue
than simply saying, "no dollar value can be placed on preserving or saving human life."
146 For example, Congresswoman Verla Insko introduced a proposal for the amendment of North
Carolina's state constitution to make health care a fundamental right for all residents. John Hood, You
Can't Create a Fundamental Right, CAROLINA JOURNAL ONLINE, May 25, 2004 at
http://216.27.16.14/articles/displaystory.html?id=1566 (last visited April 5, 2005). The Charter of
Fundamental Rights of the European Union also considers health care to be a fundamental right, though
such a position is not without opposition. See Charter of Fundamental Rights of the European Union,
Article 35: Health Care, at http://www.europarl.eu.int/charter/pdf/text-en.pdf (last visited Oct. 25,
2004). John Kerry made expanded access to health care for all Americans one of the platforms of his
presidential campaign, promising both greater coverage and cheaper cost at the same time. See Kerry
Edwards, Quality Health Care for All, at http://www.johnkerry.com/issues/health_care/fairness.html
(last visited Oct. 25, 2004).
147 One should note that emergency health care is an exception to this general reality, as The
Emergency Medical Treatment and Active Labor Act (EMTALA) guarantees access to all Americans
regardless of their ability to pay. See 42 U.S.C. § 1395dd (2000).
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natural extension is that we have a social responsibility and obligation to
provide health care for all Americans regardless of their ability to pay; or
(2) if not, we should consider the possibility of various forms of market
exchange for human organs much like we do for any other health care
treatment. Even if the reader comes down on the side of option number one,
there is no reason why the provision of life-saving organs could not be
funded by a universal state health care system to ensure access for all. If
health care is indeed a fundamental right, requiring that people pay for life-
saving medicines or operations is not morally any different than making
them pay for life-saving human organs.
148
Thus, the concept of open markets for health care services and prod-
ucts is accepted practice in the U.S., as Americans believe in exchange
systems to varying degrees in all aspects of life. With respect to organ
sales, a compelling case can be made that government regulation is neces-
sary to prevent abuse and exploitation,149 but it is much more difficult to
make the case that a market system involving the human body is altogether
immoral from the outset.
B. The Distributive Justice Argument Backfired
When Al Gore spearheaded the National Organ Transplant Act
through Congress in 1984, the noble intent was that life-saving organs
should never have to be purchased; rather, they should be a "gift" to the
recipient. 150 By promulgating such a policy, we would prevent the poor
from being exploited, and ensure that the wealthy were not the only seg-
ment of society who had access to life-saving organs.
While this goal is laudable, the reality has turned out quite differently.
Instead of organs becoming gifts to recipients who were not required to pay
for them, health care middlemen have dramatically marked up the cost of
transplant related services to capture much if not all of the surplus that was
intended to go to the recipient.'' Economists Pindyck and Rubinfeld detail
the flaws in the distributive justice rationale, noting that physicians, hospi-
tals, and other transplant service providers are able to adjust prices upwards
to take advantage of potential recipients' willingness to pay for life-saving
148 See Denise, supra note 72, at 1033 (stating that "the wealth discrimination argument logically
applies to all medical care allocated by market forces and would thus prohibit any life-saving health
care from being bought or sold").
149 See infra Part III.E.
150 See Thorne & Langer, supra note 48 (noting that while Congress' intent was that donated
organs should be a gift, economic realities have dictated the opposite).
151 See id; PINDYCK & RUBINFELD, supra note 75, at 293-94.
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transplants.152 They conclude that organs are still being allocated on the
basis of ability to pay today, directly contrary to Congress' noble intent. 1
53
Furthermore, to the extent that we worry about distributive injustice,
we must be cognizant of the reality that individuals' wealth levels influence
all kinds of health care decisions and outcomes that occur in the U.S. al-
ready. It is no secret that wealthy people tend to live longer and healthier
lives than their poorer counterparts. 154 In addition, despite egalitarian con-
cerns in the U.S., roughly 43 million Americans at this very moment pos-
sess no health care insurance coverage at all.' 55 If society were to put its
money where its mouth is, this deplorable lack of coverage would certainly
be remedied. Yet every attempt to pay for universal health care coverage in
recent memory has died a painful political death,'56 leaving the "haves" and
the "have nots" in continued unequal positions. As a result, there is no
question that one's wealth level directly impacts their health level.
On the other side of the philosophical coin, Congress should acknowl-
edge that while distributive justice arguments may lie behind its decision to
outlaw a market-based approach to organ donation, such a determination is
overtly paternalistic. 57 Libertarian critics might contend, "who are we to
say that our judgment regarding the propriety of organ sales should super-
sede that of a poor person's? If she values $50,000 more than she values
her kidney so that she can fund education or provide food for her family,
why does society have the right to tell her she's wrong?" Thus, if the choice
comes down to starving her children versus living with one kidney while
being able to provide for them, isn't the poor person (and even society)
152 See PINDYCK & RUBINFELD, supra note 75, at 293, fig. 9.7. Thorne & Langer, supra note 48.
Thorne and Langer argue that since individuals on the waitlist for organs are willing to pay a certain
amount for a transplant (regardless of who the money goes to), the physicians and medical teams in-
volved may be able to raise prices accordingly to reap the patient's entire value of the transplant, not
just the portion attributable to their medical services. Id. Hence, the value of the new kidney may not be
a gift to the recipient, but rather may be captured in the form of increased payment to the medical serv-
ice providers. Id.
153 See PINDYCK & RUBINFELD, supra note 75, at 293, fig. 9.7. See also Michele Goodwin, Altru-
ism's Limits: Law, Capacity, and Organ Commodification, 56 RUTGERS L. REV. 305 (2004) (exploring
the clandestine private organ negotiation process, and noting the limits to altruism); Michele Goodwin,
Commerce in Cadavers is an Open Secret, L.A. TIMES, Mar. 11, 2004, at B15.
154 See generally JOHN ARCHIBALD LAW ROBERTSON, DECIDE THE NUCLEAR ISSUES FOR
YOURSELF: NUCLEAR NEED NOT BE UNCLEAR (2003) , at www.magma.ca/-jalrober/Chapter6a.htm
(last visited Oct. 25, 2004) (noting that life expectancy correlates with per capita GDP, and that while
wealth does not necessarily cause better health, it allows for it).
155 Press Release, Econ. Statistics Admin., U.S. Census Bureau, Numbers of Americans With and
Without Health Insurance Rise, Census Bureau Reports (Sept. 30, 2003), at
http://www.census.gov/Press-Release/www/2003/cbO3-154.html (last visited April 5, 2005).
156 See Clinton's Failure: Health Security Reform Plan of 1993, a t
http://my.netian.com/-pynchon/doc/healthcare.htm (last visited Oct. 25, 2004).
157 See Hansmann, supra note 9, at 72. See also Finkel, supra note 84.
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better off than she was previously? If society does not believe so, it is only
because we think that we know better than sellers do what is best for
them. 15
8
Finally, proponents of the distributive justice rationale for the ban on
organ sales are rightly concerned that a legalized market would give the
wealthy an overwhelming advantage when it comes to the ability to pur-
chase and receive life-saving organs.159 However, this fear could be allevi-
ated by government provision of funding for organ purchases based on in-
come or wealth levels of potential buyers.' 60 While the wealthy could fend
for themselves and would not require state assistance, the poor could be
granted vouchers by the government that would cover all or part of the or-
gan purchase price depending on the individual's need. In this manner, we
could remove the concern that poor individuals would not be able to afford
the purchase of organs, as they would be placed on a level playing field in
the open market through responsible government assistance.
However, even if society could ensure that both rich and poor would
have equal access to organs, it would still face that perverse distributive
consequence that poor persons would disproportionately be the organ sell-
ers of the world. 161 At least one virtue of the United States' no-sale system
is that it prevents the problem of poor Americans being preyed upon to
become donors. The same cannot be said across the rest of the world, where
black markets in organs that exploit the poor continue to thrive.' 62 Agents
158 In a tangential field, Alan Schwartz has argued that paternalistic decisions to invalidate certain
contracts as unconscionable (in the avowed interest of protecting the weak) ultimately harm the class of
people that society is trying to protect. See Alan Schwartz, A Reexamination ofNonsubstantive Uncon-
scionability, 63 VA. L. REV. 1053, 1053-59, 1061-64, 1071-82 (1977). As a result, Schwartz contends
that the paternalism of the rich actually hurts the poor. Id.
159 See Williams, supra note 105, at 316 (stating that "[o]ften, it is the poorer citizens of develop-
ing countries who are supplying organs for the members of the upper class who can afford them").
160 JAMES F. BLUMSTEIN, THE USE OF FINANCIAL INCENTIVES IN MEDICAL CARE: THE CASE OF
COMMERCE IN TRANSPLANTABLE ORGANS, IN JUSTICE AND HEALTH CARE: COMPARATIVE
PERSPECTIVES 9, 31 (Andrew Grubb & Maxwell J. Mehlman eds., 1995) (stating that "wealth inequality
... is unacceptable as a basis for deciding which persons are to be recipients of organ transplants" and
that this problem "could be assuaged by ... instituting public subsidy for those whose inadequate level
of wealth bars access"); Gregory S. Crespi, Overcoming the Legal Obstacles to the Creation of a Fu-
tures Market in Bodily Organs, 55 OHIO ST. L.J. 1, 52 (1994) (noting that a market in organs would
require the establishment of public or private mechanisms to subsidize organ purchase for potential
recipients who otherwise would be denied access); see Denise, supra note 72, at 1033, n.146 (citing
Note, Tax Consequences of Transfers of Bodily Parts, 73 COLUM. L. REV. 842, 842 (1973)).
161 See Williams, supra note 105. But cf. Sowell, supra note 123. Sowell argues that banning sales
does not alleviate the problem of poverty and challenges the accepted wisdom that purchasers of organs
would have to be wealthy. Id. He points out that if we are really concerned about the poor, we can have
the government serve as the purchaser of organs instead of individuals. Id.
162 See supra Part I.C; see also Maria N. Morelli, Note, Organ Trafficking: Legislative Proposals
to Protect Minors, 10 AM. U. J. INT'L L. & POL'Y 917 (1995) (discussing rumors of black markets in
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make a lucrative living by scouring slums for the downtrodden, poverty-
stricken souls in society, and promising them riches in return for the sale of
a kidney. 63 While these poor individuals sometimes give in to the tempta-
tion of a cash reward that they believe will change their financial fortunes
well into the future, it is predominantly the agents and middlemen who reap
the lion's share of the profits."6
In sum, while the distributive justice rationale for banning sales was
based on the best of intentions, its force has been weakened by subsequent
developments. In the U.S., organs are still rationed to a significant extent
based on one's ability to pay, giving the wealthy a decided advantage even
under current law. A move to any market system could be accompanied by
government assistance to enable the poor to purchase organs on an equal
footing, but any system faces the problem that poor individuals would
overwhelmingly be placed in the unenviable position of being organ sellers.
C. Information Problems Could Be Corrected
Two separate responses may be offered to address the lack of infor-
mation problem faced by potential organ sellers. First, we could educate
sellers about all health risks that they were about to incur to ensure their
decision be fully informed and to reduce the chance they would later regret
it. Second, if a person still prefers to sell her kidney despite those risks be-
cause having money to buy food and avoid starvation is worth losing the
kidney, we must be willing to be overtly paternalistic if we still desire to
override her decision.
Risk information and education could entail putting potential organ
sellers through mandatory classes on the dangers involved in live-person
organ donation. 65 A bevy of written materials concerning health outcomes
could be produced and distributed; a person could even be required to take
a short exam to demonstrate that they understood the risks they were vol-
untarily incurring. Even so, given the predicament of poverty which moti-
North America, Europe, Israel and Latin America).
163 See Sanjoy Hazarika, India Debates Ethics of Buying Transplant Kidneys, N.Y. TIMES, Aug.
17, 1992, at A20.
164 See id
165 Most reports have shown that organ donation by living individuals is not as risky as one might
think. See Leora Erun Frucht, A Life for a Life, THE JERUSALEM POST, Feb. 14, 2003, at 12 (noting that
donors very rarely suffer from medical problems even thirty years later and that the operation itself is
low-risk). However, there may be substantially greater risks imposed on third-world organ sellers who
face dirty drinking water and increased chances of infection compared to their counterparts in developed
nations. See Finkel, supra note 84.
[VOL. 13:1
UTILIZING INCENTIVES TO END AMERICA'S ORGAN SHORTAGE
vates most sellers (and perhaps lack of education as well), one must wonder
whether informing them of all the risks would do much to change their
minds.
If education is not the answer, then societal paternalism rather than
imperfect information becomes the justification for banning organ sales.
There are indeed many members of society who believe it is unacceptable
to receive money in exchange for agreeing to take on any risk to human
life. 166 However, this argument ignores the reality that we already sanction
this practice every day, and that individuals demand increased payment to
reflect risks incurred. 6 7 For instance, we need look only to the variety of
dangerous occupations that we allow (and need) individuals to occupy.
Firemen, policemen, and members of the military all take significant risks
to their health on a daily basis, and are compensated for it with enhanced
wages that reflect the "risk premium" they are voluntarily bearing in the
interests of saving other people's lives. 168 In fact, the overall risk posed by
many socially acceptable dangerous professions is far greater than the risk
that an individual bears when she agrees to donate or sell one of her organs
to save another human being's life.'69 Many of these sellers are living in
horrific poverty; the chance to receive a few thousand dollars to escape the
slums in exchange for taking on an added risk to their health is rational and
well worth it.'7° It is overtly paternalistic to assume that those who make
the decision to sell an organ do not know what they are doing.
166 See, e.g., Sullivan, supra note 12 (quoting Dr. David A. Ogden, President of the National Kid-
ney Foundation, who believes "[iut is immoral and unethical to place a living person at risk of surgical
complication and even death [in exchange] for a cash payment"). Despite this position, society has little
problem permitting thousands of Americans to undergo cosmetic plastic surgery annually, even though
there are certainly risks to life involved and little or no benefit to others. At the same time, we are will-
ing to tell people who want to undergo surgery that would save another person's life-and perhaps
provide for their own family as well-that they cannot do so in exchange for payment.
167 See W. Kip Viscusi, Job Safety, in THE CONCISE ENCYCLOPEDIA OF ECONOMICS, at
http://www.econlib.org/library/Enc/JobSafety.html (last visited April 5, 2005). Viscusi notes that work-
ers do demand some wage premium to reflect the dangers inherent in certain jobs. Id. Analogously,
society allows women to make the decision to become surrogate mothers in exchange for payment, even
though such a choice entails nontrivial physical and psychological risks to the mother's health.
168 See id.
169 How to Be a Living Donor, at http://www.shareyourlife.org/becomejlivingdonor.html (last
visited April 5, 2005) (stating that "there is little danger in living with one kidney" because "[t]he re-
maining kidney will enlarge to do the work that two healthy kidneys share." Further, "[t]he liver has the
ability to regenerate and regain full function. Lungs and pancreas do not regenerate, but donors usually
have no problems with reduced function."); see also, e.g., Frucht, supra note 165. But cf Finkel, supra
note 84. The author questions the notion that donation is as safe as proponents claim, pointing out that
every study finding that risks are low took place in a wealthy nation. Id. Conversely, donors with poor
diets and bad drinking water (as is the case in many black market nations) are open to a far greater risk
of infection which may compromise their remaining kidney. Id.
170 Moreover, while the amounts paid for black market kidneys seem small by American standards,
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D. Negative Externalities Can Be Insured Against
Beyond correcting risk misperceptions, we still must be concerned
about potential negative externalities imposed on society by virtue of an
individual's decision to sell (or donate) her organs. If her own health dete-
riorates as a result and society must pick up the tab for some or all of those
costs, we must find a way to internalize these negative externalities at the
individual level so that organ sellers include those costs in their own inter-
nal decisionmaking calculus.
171
One way to prevent society from having to bear unfunded costs is to
mandate that organ sellers put aside a portion of their remuneration into an
insurance fund, the sole purpose of which is to guard against increased fu-
ture health care costs due to the underlying organ sale. For instance, it can
be expected that when a seller is left with only one kidney, she faces
somewhat higher expected medical bills in the future due to the risk that the
remaining kidney fails. 172 Insurance company actuaries are quite skilled at
calculating expected costs that arise from a host of individual decisions like
these. 173 It seems likely that given the well-developed insurance markets
that exist in America, 174 actuaries would be able to gather data based on
experience that could estimate, with reasonable certainty, the expected in-
crease in health care costs due to the decision to sell one's organs. This data
could be based on the type of organ sold, other individual health risk fac-
tors (e.g., smoker versus non-smoker, pre-sale weight, and nutrition), as
well as any other variable that correlates with increased future risk from the
organ sale.
Mandating such an insurance fund would comport with accepted prac-
tice in the U.S. Today, liability insurance is statutorily required for a num-
ber of risky behaviors, most notably driving.'75 To prevent the costs from
they are often ten times the annual wages that laborers can hope to receive in third-world countries. See
Rohter, supra note 2. Selling a kidney may be viewed, then, as a rational decision to take advantage of a
once-in-a-lifetime chance to escape debt. Id.
171 While critics of human organ markets focus on the negative health consequences created by
organ sellers, it should be noted that these negative externality concerns regarding future health risks
apply equally to those who donate organs. If we fear that organ sellers are imposing unacceptable exter-
nalities on society, then we must also ask if we feel the same way about organ donors.
172 However, this risk is relatively small, as most kidney donors do not experience complications
even decades after their operation. Frucht, supra note 165, at 12.
173 See Be An Actuary: A Career Without Boundaries, What Is An Actuary?, a t
http://www.beanactuary.org/about/whatis.cfm (last visited April 5, 2005).
174 See, e.g., STEVEN SHAVELL, FOUNDATIONS OF ECONOMIC ANALYSIS OF LAW 266-67 n. 11
(Harvard Univ. Press 2003).
175 See Insurance Information Institute, Can I Drive Legally Without Insurance?, at
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accidents from falling onto the government, we force individual actors to
internalize those costs by requiring them to pay the insurance premium up
front. In this manner, when harm materializes, the state is not left holding
the bag. We still allow actors to engage in risky behavior because we un-
derstand it produces benefits that outweigh its costs, but only if they (or
their insurer) are willing to bear the consequences themselves.
E. Regulated Markets Might Be America 's Best Response to Black Mar-
kets
The objections to human organ sales detailed above all contain some
merit, but lose some of their force upon closer analysis and further ignore
the reality that markets in human body parts and products are, for all practi-
cal purposes, unavoidable.' 76 Morality concerns opposing commodification
of the human body are somewhat hypocritical when one considers that we
allow the explicit payment of cash for human tissues, blood, semen and
ova. 177 We also have no moral qualms about requiring individuals to pay
for medical care in general, without which their health and lives can be
expected to suffer. The argument regarding the distributive justice impact
of allowing sales (i.e., that the poor would be sellers, and only the rich
could be buyers) ignores the fact that organ transplants are still rationed on
the basis of ability to pay today.178 Further, distributive inequity could be
partially cured by providing government subsidies to enable the poor to
have equal access to available organs. 179
http://www.iii.org/individuals/auto/a/canidrive/ (last visited Nov. 3, 2004) (stating that "[ajlmost every
state requires you to have auto liability insurance"). One should note, however, that there are still many
uninsured motorists on the road, all of whom are choosing to violate the law and run the risk of legal
consequences.
176 See Mahoney, supra note 49, at 166 (arguing that "markets in human biological materials not
only exist but are for all practical purposes unavoidable, and that the ostensible debate over whether
human tissue ought to be bought and sold distracts attention from pressing questions relating to the
allocation of the burdens and benefits of the dramatic scientific advances of the past several decades").
177 For example, the Senate Labor and Human Resources Committee distinguished between the
sale of organs versus blood products because the latter are regenerative and selling them does not pose a
threat to the donor's health. See S. Rep. No. 98-382, at 16-17, reprinted in 1984 U.S.C.C.A.N. 3975,
3982; see also Mahoney, supra note 49.
178 See PINDYCK & RUBINFELD, supra note 75, at 293, fig. 9.7.
179 BLUMSTEIN, supra note 160, at 31-32 (calling for public subsidy to prevent wealth inequality
from determining who enjoys access to organs); Crespi, supra note 160, at 52; see also Denise, supra
note 72, at 1033; Laura G. Dooley and Robert S. Gason, Stumbling Toward Equity: The Role of Gov-
ernment in Kidney Transplantation, 1998 U. ILL. L. REV. 703, 707 nn.18-19 (1998) (citing to Blum-
stein's concern that unregulated markets might allow wealth inequality to dictate which patients re-
ceived organs).
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Moreover, if we cannot prevent the black markets in human organs
that continue to thrive worldwide today, a thoughtful and responsible regu-
latory solution in America might be the best response. Many scholars have
chronicled the reality that today's black markets lead to a host of abuses,
provide for no follow-up health care, and generally exploit the poor to the
wealthy's advantage. 8 ° Stephen Spurr details the potential for misrepre-
sentation and fraud against both buyers and sellers today, as prices spiral
out of control for organs that are of dubious quality.'81 Gloria Banks decries
the exploitation of society's most vulnerable individuals in the organ sale
trade, and urges legal and ethical safeguards for their protection.'82 Susan
Hankin Denise adds that a properly regulated organ market may therefore
be a better solution to the problem of scarcity than the outright ban we wit-
ness today.'83
Unlike black markets, responsible regulation of an American human
organ market could ensure that each individual's decision was competent,
voluntary, fully informed, and enduring.184 Where imperfect information
about health risks leads organ sellers to underestimate the consequences of
their decision, we could remedy that concern by requiring and providing
risk disclosure and education prior to allowing sales.'85 Furthermore, re-
sponsible regulation could prevent sellers from making hasty decisions by
180 See Spurr, supra note 134; Denise, supra note 72; Gloria J. Banks, Legal & Ethical Safeguards:
Protection of Society's Most Vulnerable Participants in a Commercialized Organ Transplantation
System, 21 AM. J.L. & MED. 45, 74 (1995).
181 See Spurr, supra note 134, at 191-92 (noting that black markets provide no warranties on their
products, and that the competitive forces enabled by open markets and legalized organ sales will help to
ensure quality).
182 See Banks, supra note 180. Maria Morelli further fears the potential for children to be pulled
into the illegal organ trade. See Morelli, supra note 162, at 920.
183 See Denise, supra note 72, at 1035-36 (arguing that regulated markets are superior to the exist-
ing ban on organ sales in the U.S.). Of course, even a well-regulated legalized market in the U.S. may
not completely eliminate black markets worldwide if patients can still find organs more cheaply abroad.
However, it is reasonable to suspect that an American market would significantly reduce the demand for
black market organs, especially given the ability of a regulated market to better ensure the quality of its
product. Furthermore, a legalized market in the U.S. (with appropriate safeguards to prevent abuse of
sellers) may lead to similar structures abroad. On the other hand, one might argue that competing mar-
kets might lead to a "race to the bottom" in terms of regulatory standards, as each country tries to gain
more market share.
184 An analogy can be drawn to various assisted suicide regulatory schemes, which almost invaria-
bly call for the patient to be making an informed, competent, voluntary and enduring decision. See Steve
P. Calandrillo, Corralling Kevorkian: Regulating Physician-Assisted Suicide in America, 7 VA. J. SOC.
POL'Y & L. 41, 91-98 (1998).
185 For instance, sellers could be required to attend an organ sale risk education class, during which
the various health risks involved could be explained in detail to remedy concerns regarding lack of
information. However, even if society could be certain that sellers were given all appropriate informa-
tion, it could not ensure against the risk of optimism bias in processing it.
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requiring reasonable "cooling-off periods" prior to sale (perhaps two to four
weeks) to ensure that their decision is an enduring one.'86 Further, strict
liability could be imposed on individuals or procurement agencies who sell
defective or diseased organs to prevent them from concealing adverse
health information that might negatively impact recipients. 187 Today's third
party organ brokering that exploits the poor would be prohibited, and organ
allocation could be made far more equitable by providing full state subsi-
dies to the poor.1 88 To prevent the risk that negative externalities would fall
on the state when organ sellers' health later deteriorated, we could mandate
that a portion of sale proceeds be set aside in an insurance fund with the
single goal of providing compensation for the future health risks and medi-
cal costs created by the decision to sell one's organs.189
Thus, given the reality of black markets, as well as the legitimate fears
regarding legalized organ sales, any viable market in human organs must
address the arguments raised by critics and contain substantial safeguards to
minimize exploitation and abuse. By regulating appropriately, we could
alleviate many of the problems faced by sellers on the black market today,
and we could compensate for the enhanced future risks that sellers would
be taking without placing the burden on the state. At the same time, thou-
sands of lives that are being lost today would be saved tomorrow.
IV. REAL REFORMS: UTILIZING INCENTIVES TO END THE NATION'S
ORGAN SHORTAGE
Despite the above analysis, any form of legalized human organ market
would be far from a utopian solution: it would be political suicide to pro-
pose, entail significant administrative costs to establish and monitor, and
remain morally distasteful to many Americans. While such markets have
been debated without much progress in the past, far less attention has been
paid to dozens of other monetary and nonmonetary incentives that could be
employed. Taking an incentive-based approach would avoid imposing risk
186 Spurr, supra note 134, at 194 (noting that sales by living donors could be safeguarded by add-
ing statutory "cooling off periods"). Waiting periods are also employed in other medical decisionmak-
ing contexts that have life-or-death consequences. For example, the Oregon Death With Dignity Act
requires that any patient seeking assisted suicide must wait two weeks before their request will be hon-
ored, a safeguard aimed at preventing a transitory desire to die. See Oregon Death with Dignity Act, Or.
Rev. Stat. §§ 127.800-97 (1998), amended by 1999 Or. Laws Ch. 423.
187 Keith N. Hylton, The Law and Economics of Organ Procurement, 12 L. & POL'Y 197, 209
(1990).
188 See supra Part III.B.
189 See supra Part III.D.
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on living donors, dramatically expand the pool of available organs, and
shock the conscience far less than allowing living-seller markets. 190
A. Monetary Incentives
1. Futures Markets: Allow Payment to Donor, but Organs Harvested
Only at Death
One of the more provocative financial incentives postulated to spur
organ supply is the creation of a "futures market."'' Scholars like Lloyd
Cohen and Gregory Crespi have suggested such markets to combat organ
shortages by utilizing market incentives to induce donation, while simulta-
neously preventing poor individuals from permanently harming their health
simply to pay off their debts.' 92 Rather than providing money to sellers in
exchange for the removal of their organs today, society could allow indi-
viduals to sell the right to harvest their organs upon their death (i.e., a fu-
tures contract). 93 If one or more of their organs were subsequently taken,
payment would be made to a beneficiary that the donor designated at the
time of entering into her futures contract.194 In this manner, we could alle-
viate the exploitation of the poor because living donor sales would be pro-
hibited. 9 Additionally, wealthy individuals would not necessarily have
190 For an excellent discussion of the role of financial incentives in the human organ debate, see
James F. Blumstein, The Use of Financial Incentives in Medical Care: The Case of Commerce in
Transplantable Organs, 3 HEALTH MATRIX 1 (1993); Curtis E. Harris and Stephen P. Alcom, To Solve
a Deadly Shortage: Economic Incentives for Human Organ Donation, 16 ISSUES L. & MED. 213
(2001).
191 See, e.g., Lloyd Cohen, supra note 14, at 2; Eric Cohen, supra note 8; Lloyd Cohen, supra note
25; Conan, supra note 43; Crespi, supra note 160, at 35-37; Hansmann, supra note 9, at 72-74; Spurr,
supra note 134.
192 See Lloyd Cohen, supra note 14; Crespi, supra note 160.
193 Lloyd Cohen, supra note 14, at 2. If desired, the futures market could be designed to apply only
to certain organs, or to last only for a certain duration (preferably short term to allow the seller to revisit
her decision periodically); see Hansmann, supra note 9, at 62. Additionally, futures markets could
include safeguards to prevent against incentivizing individuals to sign up only because they planned to
commit suicide in the near future. One method of doing so would be to institute waiting periods be-
tween the time a futures contract is entered into and the time at which a person (or their beneficiary)
became eligible to receive the compensation.
194 Lloyd Cohen, supra note 14, at 2.
195 See Crespi, supra note 160, at 6-7 (stating that the "market could be designed so that no one
would be put into the position where he would be tempted to sell a bodily organ to meet a pressing
financial exigency"). However, while the risk of abusing living donors would be reduced, many Ameri-
cans still identify a person's corpse with the notion of personhood, making even cadaveric organ sales
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greater access to harvested organs because futures markets do not deal with
the allocation of organs, but only their supply.196 Finally, the medical com-
munity would no longer need to worry about procuring the consent of the
deceased's next of kin to procure viable organs.1 97
An analogous futures market has been proposed by Henry Hans-
mann.' 98 Hansmann's idea modifies the timing and type of pay-
ment-allowing the seller herself (instead of a beneficiary) to receive a
reduction in health insurance premiums today in exchange for her promise
to allow her organs to be harvested at death.199 The seller would be able to
revisit her decision periodically, as she would elect annually either to opt in
to being an organ donor (and receive the corresponding insurance dis-
count), or elect not to do so if she so chose (and pay the traditional pre-
mium). 2°° Further, by avoiding the harvesting of organs from living indi-
viduals, we would mitigate the concern that the seller's health would sub-
sequently deteriorate and that society would be left having to pay the price
for it.
somewhat problematic. See Donald Joralemon and Phil Cox, Body Values: The Case Against Compen-
sating for Transplant Organs, 33 HASTINGS CENTER REPORT I (Jan. 1, 2003) (arguing that the exten-
sive money spent on extracting bodies from World Trade Center after the 9/11 attack reflects societal
recognition of the view that the corpse is integral to one's self).
196 Lloyd Cohen, supra note 14, at 30.
197 See id. at 34-35.
198 See Hansmann, supra note 9, at 61-71. Hansmann proposes a futures market wherein people
could (while alive and well) sell the right to harvest their organs upon their death. Id. The value of the
futures contract would be measured by the risk of the individual's death multiplied by the chance that
her organs would be harvestable multiplied by the value of those organs. Id. The government could be
the sole purchaser of the futures contracts, or health care insurers could purchase them as well if they
found it in their financial self-interest. Id. Individuals could sell futures for a term or for life, and recipi-
ents of the organs (or their insurer) would pay the list price for the organ. With futures markets, insur-
ance companies could resell rights to organs, which might lead to the problem of some companies
aggressively soliciting organ futures from high risk individuals. Id. However, an advantage of allowing
futures markets would be that the decision to sell would be made at the time when it is least problematic
(without imposing risks on a living seller), and there would no longer be any need to seek permission
from the person's next of kin after death. Id. If the seller's family objected to organ harvest by the
futures holder, we could ignore the family's protest or allow the family to prevent harvesting if they
were willing to pay the fair market value of the organ. Id. On the other hand, one unintended disadvan-
tage of futures markets could be the shrinking of the altruistic donor pool because of the distaste that
some would-be voluntary donors may associate with legalized markets. Id. Further, an individual who
has entered into a futures contract might reasonably fear that she would receive subpar medical care
after making her decision, so that her organs might be harvested sooner. Id. Hansmann concludes that in
the long run it might be better to encourage voluntary donation, but that futures markets may help in the
short term. Id.
199 See id. at 63.
200 See id. at 63.
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One wrinkle in the futures market plan is whether or not organ trans-
plant success is influenced by using a living versus deceased donor. If out-
comes are similar regardless of whether a kidney comes from a living or
dead individual, then futures markets should be just as successful as living-
donor sales, but without the accompanying risks. However, to the extent
that success rates are reduced when a transplanted organ is harvested from a
deceased donor,211 there may still remain a small black market in living-
donor sales due to the greater chance of a positive outcome. In fact, some
organ brokers convince dialysis patients today to buy organs abroad rather
than wait for an American cadaveric donor by touting the benefits of live
donation. 2 2 To the contrary, most studies have concluded that the differ-
ence in outcomes based on whether the organ was harvested from a living
or non-living individual is relatively small.20 3 If these studies are correct,
201 The United Network for Organ Sharing states that "[t]ransplants from living donors are often
more successful, because there is a better tissue match between the living donor and recipient. This
higher rate of compatibility also decreases the risk of organ rejection." UNOS, Living Organ Donation,
at http://www.unos.org/Resources/factsheets.asp?fs=2 (last visited April 5, 2005). Many studies have
documented an increased chance of positive outcomes when using organs transplanted from living
donors vis-A-vis organs transplanted from cadavers. See, e.g., J. Cecka and P. Terasaki, The UNOS
Scientific Renal Transplant Registry. United Network for Organ Sharing, CLIN. TRANSPL. 1 (1994)
(finding that survival rates for recipients of living donor kidneys were significantly higher than for those
receiving kidneys from cadavers); J. Lowell and R. Taylor, The Evaluation of the Living Renal Donor,
Surgical Techniques And Results, 12 SEMIN. UROL. 102 (1994) (concluding that living-donor renal
transplants from either genetically related or unrelated donors have proven to have superior short-term
and long-term results when compared to cadaveric transplants).
202 See Michael Pilgrim, How Easy is it to Buy a Kidney from One of the World's Poorest People?
It Took Me Just One Phone Call, MAIL ON SUNDAY, May 25, 2003, at 52, available at 2003 WL
10412829. In the United States, even with living donor transplants, there is usually a three-hour wait
between the removal of the organ and the transplant operation because one surgical team performs both
operations. Id. Transplant brokers boast that their transplants are done ten minutes after removal of the
organ because two teams of doctors are involved. Id. Additionally, many transplant brokers conduct
testing for one month to ensure the match and health of the organ. Id. With cadaveric organs, medical
professionals do not have the luxury of taking a month to do such testing. Id.
Interestingly, prior to the 2003 Iraqi war, Iraq had one of the world's safest and most affordable
markets for living-donor kidneys. See Finkel, supra note 84. In fact, one Israeli doctor has expressed
that, although it is technically illegal to buy organs in Iraq, Iraq would be the place to go to pay for a
transplant. See id. He noted that the percentage of his patients whose organs were still functioning one
year after receiving a living donor transplant abroad, in countries like Iraq, was higher than anywhere
else in the world, including the United States (which primarily uses cadaveric organs). Id. Iraq uses
living donors, has excellent surgeons, carefully screens sellers for health complications and organ
matches, and provides excellent post-operative care. See id. However, Iraq's black market is likely no
longer thriving after the U.S. led invasion of the country in 2003.
203 See, e.g., R. Knight et al., The Influence of Acute Rejection on Long-Term Renal Allograft
Survival: A Comparison of Living and Cadaveric Donor Transplantation, 72 TRANSPLANTATION 69
(2001). The authors found that five-year survival was 90% for those receiving transplants from living
relatives and 88% for those receiving cadaveric transplants. Id. Furthermore, a cadaveric graft that was
free from acute rejection three months after transplantation had an equal likelihood of functioning at
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futures markets could solve our nation's organ supply crisis without reduc-
tion in health outcomes. Even if the opposite is the case, futures markets are
a solid step in the right direction, and certainly a substantial improvement
over current organ supply incentives.
2. Tax Breaks
Another financial carrot with which a few state governments have ex-
perimented is a tax deduction designed to induce their citizens to become
organ donors. Wisconsin, for example, passed a law in 2004 which allows
for a tax deduction of up to $10,000 to cover expenses resulting from a
resident's decision to donate organs, including their travel, lodging and lost
wages.2 °4 Supporters hail the bill as "the most ambitious move [yet] by a
state government to increase transplants. 20 5
Critics respond, however, that such a direct monetary incentive runs
afoul of NOTA's prohibition on paying valuable consideration for human
organs.2 °6 Howard M. Nathan, president and chief executive of the Gift of
Life Donor Program, worries, "When you get as high as $10,000 you start
to wonder what that means to people and if there is some coercion that goes
on with that., 20 7 Wisconsin legislator Steve Wieckert dismisses this con-
cern, noting, "We want[ed] to be very careful that we are not getting into
five years as that of a graft from a living related donor. Id; see also Splendiani et al., supra note 131
(finding an organ survival rate of 97% for living donor transplants versus 93% for cadaveric trans-
plants); K. Nishikawa and P. Terasaki, Annual Trends and Triple Therapy-1991-2000, CLIN.
TRANSPL. 247 (2001) (The study reported that cadaver donor graft survival at one year improved from
84% in 1991 to 90% in 2000, while one-year graft survival of living donor transplants only improved
from 93% in 1991 to 95% in 2000. Further, triple therapy virtually eliminated the effect of sensitization
for cadaveric donor grafts.)
204 Napolitano, supra note 16. "The bill was overwhelmingly approved by the Wisconsin State
Assembly in November [2003]," and "passed in the Senate by a vote of 28 to 2." Governor James E.
Doyle, a Democrat, was eager to sign it into law, stating "I'm very supportive .... This is a big issue in
Wisconsin." Id.
205 Id. One should note that Wisconsin's tax break proposal is aimed at incentivizing donation by
living individuals. Tax breaks for donation after death could likewise increase the pool of available
organs.
206 Id.
207 Id. One of the only state representatives to vote against the bill, Bob Ziegelbauer, added that the
deduction "would needlessly complicate the tax code . . . at a time when [Wisconsin] faces a fiscal
crisis. Why should the government be in the business of handing out rewards to people when they do
good things?" Id. One might respond that governments exist in large part to incentivize private actors to
act in socially beneficial ways.
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the business of selling organs but [instead] encourag[ing] organ dona-
,,208tion.
Other states, including Indiana, are considering nearly identical legis-
lation. 2 9 Nearby Kansas contemplated passing a similar tax break for blood
and organ donation in 2000, but the bill never emerged from the committee
process after the state attorney general authored an opinion that it violated
NOTA's ban on paying valuable consideration.1 ° Outside of our national
boundaries, countries like Great Britain have also weighed the impact of tax
breaks as a partial solution to alleviate growing organ shortages.211 Finally,
Israel proposed a law which would provide financial reimbursement to do-
nors for the time, discomfort, and inconvenience involved due to their deci-
sion to donate organs.212
Assuming tax deductions do not overstep the bounds outlined by fed-
eral law in the U.S., 213 they represent a provocative move toward explicit
consideration of pecuniary incentives to spur donation. On the downside,
they only work if the state in question has an income tax,214 and even if it
does, tax deductions are peculiarly regressive-i.e., a wealthy individual in
the highest marginal tax bracket would receive a greater financial benefit
than would her poorer counterpart in a lower bracket. This inequity could
be remedied by provision of a tax credit regardless of income instead of a
208 Id.
209 Id.
210 Napolitano, supra note 16.
211 See Human Organs: Not for Sale, THE GUARDIAN (MANCHESTER), Dec. 4, 2003, at 27.
212 Frucht, supra note 165. However, this expenditure is not to be considered "payment for the sale
of an organ," and is only allowed as long as the Ministry of Health is convinced that there is no mone-
tary incentive behind the donation. Id.
213 The fundamental argument raised by opponents is that a tax break constitutes the payment of
"valuable consideration" in contravention of NOTA's mandate. See 42 U.S.C. § 274e(a) (2000). This
argument will be addressed infra in Part IV.A.3. There, I suggest that state governments might discount
driver's license fees for those who check the organ donor box. To combat the response that such a
benefit runs afoul of NOTA by compensating people for their decision to donate, the state could simul-
taneously offer a tax credit in the same amount to its citizens who refused to donate. Despite the fact
that no additional valuable consideration would be given to encourage donation, my intuition is that
many individuals will choose to opt in to donation in order to receive the discount immediately rather
than wait until April 15th to receive the equal tax credit.
214 Seven states currently do not impose an income tax on their residents (they are Alaska, Florida,
Nevada, New Hampshire, South Dakota, Tennessee, Texas, Washington and Wyoming). List of States
Without In c o m e Tax, a t
http://encyclopedia.thefreedictionary.com/List%20o / f2States%20Without%20Income%2Tax (last
visited April 5, 2005). Even in the majority of states that have some version of an income tax, the rate at
which citizens are taxed from state to state varies greatly. Some might also reasonably question whether
people would truly be incentivized to donate organs solely based on receiving a tax break. The same
argument could be made regarding federal income tax treatment of charitable donations-do people
donate to charities because of the tax advantages or do they do so independent of any financial carrots?
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tax deduction. Furthermore, if tax breaks for living donors succeed, we
should expand them to include tax incentives for donation after death as
well. Moreover, a uniform federal tax credit (rather than inconsistent state
efforts) would allow all Americans who wished to donate to benefit equally
from their magnanimity.
3. Discounted Driver's License Fees
Rather than waiting for a tax credit to arrive come April 15th, a more
immediate financial incentive to donate could be given directly to people
when they receive or renew their driver's licenses. Today, Americans have
the option to register as organ donors when they obtain their licenses. Most
choose not to opt in, despite the fact that a large majority of these individu-
als actually support the idea of organ donation.215 What explains this para-
dox? It is easier to do nothing than it is to act.
One simple solution to capitalize on the fact that indifference is caus-
ing many Americans not to opt in is to offer a discount or waiver of any
driver's license renewal fees in exchange for their decision to check the
organ donor box.216 Every state imposes some nominal fee to cover the
administrative costs of its department of motor vehicles (DMV). Georgia,
for instance, offers its residents a $9 discount for their agreement to become
donors, although the new state governor has indicated his intention to re-
scind the program because of uncertainty over its legality and a desire to
raise state revenues.217
Discounting driver's license fees raises the same kind of concerns as
do tax breaks regarding the legality of providing valuable consideration in
exchange for a person's decision to donate human organs. However, a
unique combination of the tax break and discounted driver's license fee
proposals should suffice to remove any legal concerns. First, the state DMV
could offer to waive the license fee immediately to a driver who checked
215 See Kurtz & Saks, supra note 21, at 782-83; Hazony, supra note 60, at 236-39 (addressing the
paradox between public opinion in favor of organ donation versus the actual rate of donation, and hy-
pothesizing that the difference may be due to psychological and emotional issues hindering the dece-
dent's family from consenting at the time of death, as well as health care providers' discomfort when it
comes to requesting donation); Pew Research Center for the People and the Press, supra note 10 (find-
ing that 81% of the public supports donation but only 42% have registered as donors).
216 See Hansmann, supra note 9, at 63.
217 See Tabarrok, supra note 6. There is concern that the law may not be legally valid due to
NOTA's prohibition on the payment of valuable consideration for organs. See id. Georgia's governor
may also rescind the $9 offer simply to increase state revenue. Id. Such shortsighted financial decisions
ignore the literally hundreds of thousands of additional dollars that Americans on organ waitlists impose
on our health care system.
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the organ donor box at renewal time. To combat the argument that this rep-
resented a payment to donors in violation of NOTA, a tax credit in the same
amount could be provided to non-organ donors at the time they completed
their federal tax form. In this manner, both organ donors and non-organ
donors would be placed in identical financial positions-there would be no
greater valuable consideration provided to organ donors. The only differ-
ence would be the timing-organ donors would receive the waiver of li-
cense fees at the counter or in the mail when they renewed their license,
and non-donors would receive the identical waiver as a tax credit come
April 15th.
Some might wonder then, "If the financial outcome to both donors and
non-donors is the same, how would this system incentivize organ donation
any better than the status quo?" The simple answer is that individuals (who
are relatively indifferent or mildly in favor of organ donation) will often
choose the option which is "easier." It is easier to receive a waiver of fees
at the time of renewing one's driver's license than it is to wait until April to
claim one's tax credit. This system would involve minor costs to the state,
and could even be offset by raising fees or taxes in other areas, if necessary.
Yet, it could reap enormous gains in the percentage of Americans who
opted in to organ donation. Currently, over 80% of Americans support the
concept of organ donation," 8 yet only approximately one-quarter go
through the trouble to opt in.219 By waiving driver's license fees in the
manner just described, it is reasonable to surmise that far more individuals
will exercise their preference to opt in, if only to avoid having to fill out the
paperwork to receive a future tax credit. Non-donors would not be able to
complain about unequal financial treatment based on their decision to opt in
or not, because they would receive the same amount of money as their do-
nor counterparts. 2 ° The moral of the story: simply requiring people to go to
218 See Pew Research Center for the People and the Press, supra note 10 (finding 81% of those
surveyed support the donation of organs for transplant); The Gallup Organization, Inc., supra note 10
(85% of those polled were in favor of organ donation by a loved one and 60% said they would be will-
ing to donate their own organs); see also Kurtz & Saks, supra note 21, at 768 (noting that the support
for organ donation expressed in the 1993 Gallup Poll was surpassed in a 1995 Iowa study, in which
97% of residents interviewed expressed approval for organ donation); Hazony, supra note 60, at 220.
219 See The Gallup Organization, Inc., supra note 10 (28% of respondents indicated they had
signed organ donor cards); Hansmann, supra note 9 (citing to a survey indicating that just 17% of
Americans were registered donors).
220 Non-donors might still complain about the delay in payment (and the corresponding declining
purchasing power of money over time) since their decision forces them to wait until tax season to re-
ceive the tax credit. If that becomes a major policy concern, the state could even offer to pay non-donors
a nominal amount of interest to compensate for the delay in payment. My intuition is that the great
majority of individuals who are indifferent to organ donation or who are mildly in support would still
check the box opting into organ donation in order to receive the discounted driver's license fees imme-
diately rather than wait and receive the time-premium in the form of a tax credit later.
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the trouble of filing for a tax credit to opt out will encourage the great ma-
jority of Americans to opt in to organ donation up front.22'
4. Reimbursement of Medical Care and Burial Expenses of Donors
Peter Young makes the point compellingly: why do we allow hospi-
tals, medical teams and organ transplant service providers to make thou-
sands of dollars from each organ donated, yet we do not permit the families
of donors to receive a dime, even for burial costs. 222 He recounts the tragic
tale of Susan Sutton, a 28-year-old who claimed her own life by gunshot
after a fight with her boyfriend.223 Her family made the difficult but consci-
entious decision to donate her organs so that others might receive the gift of
life through her painful death.224 Her heart, liver, corneas, and some of her
bones and skin were used for transplantation.225 The hospital and medical
teams who performed the transplant made thousands, as did the nonprofit
transplant coordination agency who arranged the transfers. 226 The family
received nothing. They buried Susan Sutton in an unmarked grave, unable
to even afford a gravestone to preserve her memory.227
At the very least, tragic stories like Susan Sutton's highlight the case
for providing some financial remuneration to families of donors, if only
limited reimbursement for end-of-life medical care and funeral expenses.
Professor Fred Cate of Indiana University adds, "we sell body parts all the
time; we just don't call it that .... What the advocates are saying is, 'Let's
call a spade a spade. And let's not exclude the donor or the donor's family
from a market that everyone else is participating in."' 228 A. Bruce Bowden
of the National Kidney Foundation agrees, asking that "the law be changed
to permit payments of burial expenses for donors." 229 He suggests a "stan-
dardized and small amount," even just $2,000, paid "through an agency like
the Health Care Financing Administration to a third party, like a funeral
221 Of course, we could create a presumption of consent to organ donation at the time of registra-
tion or renewal of one's driver's license. See infra, Part IV.B.3.





227 Id. Susan's mother Judy Sutton adds, "It's wrong that doctors make so much money off donors
.... [while we] had to borrow money for the funeral." Id.
228 Young, supra note 8. Professor Cate has also written a provocative article detailing the role of
law in the organ transplantation debate. See Fred H. Cate, Human Organ Transplantation: The Role of
Law, 20 J. CORP. L. 69 (1995).
229 Young, supra note 8.
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director."23 Shelby Robinson has authored an article in support of this type
of "death benefit," arguing that such an incentive is the most viable of the
various proposed systems for increasing organ procurement in the United
States.23'
Turning from theory to practice, Pennsylvania established the first
death benefit program in the U.S. as part of 1994 legislation creating the
Organ Donation Awareness Trust Fund.232 In response to the organ short-
age (and specifically its disproportionate impact on African-Americans),233
the state permits its residents to make voluntary $1 contributions aimed at
offsetting medical and funeral expenses of donors.234 Approximately $300
per donor is allocated for this purpose,235 a step in the right direction, but
one which is still far short of actual expenditures incurred. Other money in
the fund is allocated for developing organ donation awareness programs
within the state.236 A few other states have followed Pennsylvania's lead in
230 Id. (internal citations omitted). Furthermore, the Ad Hoc Committee for Solving the Intractable
Organ Shortage (AHCSIOS) has proposed a $5,000 payment to the estate of the deceased, suggesting
inter alia that the money can be used to help offset funeral or hospital expenses. AHCSIOS, at
http://www.pitt.edu/-htk/organgiving/proposal.htm (last visited April 5, 2005).
231 Shelby E. Robinson, Organs for Sale? An Analysis of Proposed Systems for Compensating
Organ Providers, 70 U. COLO. L. REV. 1019, 1050 (1999).
232 Siegel, supra note 23, at 940-41. Siegel believes that pilot programs modeled after Pennsylva-
nia's approach are the best way to create an incentive scheme for organ donation that bridges the gap
between the status quo and a full-fledged market. Id. at 953. She also notes that Pennsylvania's program
brought to the forefront the ethical debate over paying monetary benefits to induce donation, and that
concern was expressed that its provisions violated NOTA. Id. at 941. "The program was developed with
awareness of these legal and moral obstacles, and provides a small token of appreciation to donors as
opposed to a strong financial incentive." Id. at 942.
233 Peter A. Ubel et al., Pennsylvania's Voluntary Benefits Program: Evaluating an Innovative
Proposal for Increasing Organ Donation, 19 HEALTH AFFAIRS 206, 206-207 (Sept./Oct. 2000). Afri-
can-Americans are negatively impacted because adequate antigen matches are rare. Id. at 206. Bill
Robinson, a Pennsylvania state legislator with primarily African-American constituents, sponsored the
legislation. Id. at 206-207. According to UNOS, African-Americans face an unbelievable median wait-
ing period of 1,335 days to receive an organ. Community Outreach in Donation and Transplantation
Improving for African Americans in Maryland, a t
http://www.mdtransplant.org/lncommunityoutreach.html (last visited November 15, 2004);
http://www.umm.edu/news/releases/transplant-wait_4-25-02.htm (last visited November 15, 2004).
234 Ten percent of the fund may be spent each year for this purpose, although the compensation
must be paid directly to the funeral home or hospital, not to the donor's family or estate. Siegel, supra
note 23, at 941.
235 Id. "Although the Act stipulates a maximum of $3,000 compensation per family, Pennsylva-
nia's Organ Donor Advisory Committee has decided that the payments should approximate $300 per
family. According to Kevin Sparkman, legislators determined the amount based on the estimated
amount in the fund and the estimated number of potential donors in Pennsylvania in a given year." Id.
236 Id. at 941-42. The Act allocates half of the funds raised for grants to certified organ procure-
ment organizations to develop public awareness programs regarding donation. Fifteen percent goes to
the Department of Health to further Project-Make-A-Choice, and "twenty-five percent is allocated to the
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some manner,237 but far more legislatures should consider the incentivizing
effect of providing some amount of burial compensation to reward donors
and their families who have made the decision to give the gift of life.
5. Recent Congressional Proposals
Recently, Congress has begun to show signs of interest in tinkering
with the nation's dire organ shortage. The Organ Donation & Recovery
Improvement Act,238 sponsored by Congress's lone physician Bill Frist,
authorizes the Department of Health and Human Services to carry out dem-
onstration projects that include financial incentives to increase organ sup-
ply. 239 For instance, donors may now be reimbursed for travel and subsis-
tence expenses incurred due to their decision to save someone else's life.24
Further, the Act makes financing available for Organ Procurement Organi-
zations to better coordinate donations, as well as for new organ donation
programs to be instituted at hospitals nationwide. 4' Ideally, the Act will
also improve education and training of health care professionals regarding
the need to sensitively ask families to consent to organ donation. Hospitals
could even hire special donation counselors under the guidelines of the law
that specialize in this difficult yet vital task.242
The AMA has endorsed the Act and the trial financial incentives it in-
cludes, a move which surprised some commentators.243 In fact one critic
charged, "With staggering amorality, our medical elite now think it's OK
for us to sell our body organs. ''244 However, one would think that the most
observers would be thrilled at the prospect of exploring incentives to induce
Department of Education for implementing programs in secondary schools." Id.
237 See infra Part IV.B.6 (describing organ donation awareness programs in Delaware, Ohio and
Florida).
238 Organ Donation & Recovery Improvement Act, Pub. L. No. 108-216, 118 Stat. 584 (2004).
Three related bills were also considered: H.R. 3926, 108th Cong. (2004); H.R. 399, 108th Cong. (2003);
and S.573, 108th Cong. (2003). Newspaper accounts highlighted the explicit inclusion of financial
incentives as a way to motivate increased organ donation. See Jim Warren, Congressional Spotlight
Shines on Increasing Donation by Offering Financial Incentives, 13 TRANSPLANT NEWS, Issue 11, June
14, 2003; Carey Goldberg, Fiscal Incentive Weighed to Boost U.S. Organ Supply, BOSTON GLOBE, Oct.
8, 2003, at AI.




243 Laing, supra note 120.
244 Id.
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donation, as cost-benefit studies have demonstrated that each kidney trans-
planted saves $200,000 to $400,000 in insurance costs.245
Other recently proposed Congressional bills include the DONATE
Act,246 the Living Organ Donor Protections Act,247 and H.R. 4042.248 The
DONATE Act sought to promote organ donation by providing twenty-four-
hour-per-day access to state donor registries,249 while the Living Organ
Donor Protections Act aimed to ensure that health insurance companies
could not discriminate on the basis of organ donation status. 250 H.R. 4042
would amend the Internal Revenue Code of 1986 to allow a tax deduction
for expenses paid in connection with organ donation.25' Unfortunately, pro-
posals along these lines continue to prove uncertain, as critics lament the
explicit inclusion of financial incentives as a way to motivate donors.252
This concern brings us back to the heart of the debate over valuable consid-
eration in exchange for human organs-we see that even limited, trial at-
tempts to explore fiscal incentives are likely to encounter some resistance.
On balance, however, there is support for using at least some financial in-
centives to increase organ donation and procurement, making such an ap-
proach a potentially attractive one in our quest to save Americans currently
on the national organ waitlist.
B. Non-Monetary Incentives
Besides the multitude of proposed fiscal incentives to spur donation,
there are numerous ways that society could increase private motivation to
donate organs without spending a single cent. No critic could raise an ob-
jection founded upon NOTA or UAGA, and thousands of lives would be
saved in the process.
245 Warren, supra note 238.
246 S. 376, 108th Cong. (2004).
247 S. 186, 108th Cong. (2004). A related bill designed to protect donors is the Living Organ Donor
Job Security Act of 2003, H.R. 1381, 108th Cong. (2003).
248 H.R. 40421H-, To Amend the Internal Revenue Code of 1986 to Allow a Deduction for Ex-
penses Paid in Connection with the Donation of an Organ, 108th Cong. (2004).
249 S. 376, 108th Cong. § 371A(b)(2) (2004).
250 S. 186, 108th Cong. § 3(b) (2004).
251 H.R. 4042, 108th Cong. § 214 (2004).
252 See Jim Warren, Passage of Much Needed Transplant Bill May Depend on Finding Compro-
mise on Financial Incentives Trial, 13 TRANSPLANT NEWS (Transplant Communications, Inc., Balti-
more, Md.), June 27, 2003, available at LEXIS, Newsletter Stories (discussing challenges to Bill Frist's
Senate bill to hold a test trial to determine if monetary incentives actually work).
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1. Priority Based on One's Own Willingness to Donate
Basing waiting list priority on the patient's own willingness to donate
may inspire millions of Americans who have previously not taken the trou-
ble to sign up to instead choose to opt in to donation. This concept has been
put into practice by LifeSharers, a nonprofit organization formed just over
two years ago that aims to utilize a person's internal motivation to save
their own life to save the lives of others.253 LifeSharers incentivizes people
to become organ donors (and to become a LifeSharers member) by giving
them the return promise that all members of the organization agree to do-
nate their organs first to other members before they go into the nationwide
waiting pool.254 In this manner, people are encouraged to opt in to donation
who otherwise might not, if only from a selfish desire to increase the likeli-
hood that they will be able to find a suitable organ should their own organs
fail sometime in the future. To prevent adverse selection (i.e., people join-
ing only because they are currently in need of an organ),255 LifeSharers
253 See LifeSharers, supra note 18; Steve P. Calandrillo et al., LifeSharers: An Opting-In Paradigm
Already in Operation, 4 AMER. J. BIOETHICS 17 (2004). After LifeSharers' Executive Director, Dave
Undis, read my views on organ donation in the Seattle Times, he invited me to join the organization as
an advisor. In that capacity, I provide strategic guidance regarding ways to increase organ donation
awareness and ways to incentivize more Americans to opt in. However, the views contained in this
paper are my own, and do not necessarily represent those of LifeSharers. See also Steve Calandrillo, A
Gift for Life, SEATTLE TIMES, Dec. 25, 2004; Robert Mak, Group Wants to Improve Odds of Getting
Transplant, KING 5 TV News, Feb. 14, 2005 (television interview covering my involvement with
LifeSharers).
254 See id. UNOS currently gives live organ donors priority access if they ever need an organ later
in life-so LifeSharers' provision of priority based on willingness to donate after death is simply an
extension of this concept.
LifeSharers' homepage states:
LifeSharers members promise to donate upon their death, but they give fellow members first
access to their organs. As LifeSharers members, you and your loved ones will have access to
organs that otherwise may not be available to you. As the LifeSharers network grows, more
and more organs may become available to you-if you are a member.
Even if you are already a registered organ donor, you should join the LifeSharers network.
By doing so, you will have access to organs that otherwise may not be available to you.
Id. Further, the laws of all fifty states allow for "directed organ donation"--i.e., a LifeSharers member
can lawfully designate that they want another member to receive their organs first if there is a member
in need. See LifeSharers, Frequently Asked Questions, at http://lifesharers.com/faq.asp (last visited
Nov. 5, 2004) [hereinafter LifeSharers, Frequently Asked Questions] (citing to 42 C.F.R. § 121.8
(1999), which states that "[n]othing in this section shall prohibit the allocation of an organ to a recipient
named by those authorized to make the donation.").
255 In insurance markets, adverse selection refers to the dilemma that the sickest members of a
given group will be the ones to sign up for insurance, simply because they know that they are the most
likely to need it. This presents a real problem, because relatively healthy individuals will be disincen-
tivized from buying the same insurance since they know they will be cross-subsidizing the sicker mem-
bers of the group. See generally Steve P. Calandrillo, Eminent Domain Economics: Should "Just Com-
pensation " be Abolished, and Would "Takings Insurance " Work Instead?, 64 OHIO ST. L.J. 451, 526
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imposes a six-month moratorium between the date one joins the organiza-
tion and the date that they are entitled to priority to other members' or-
gans.2 56
LifeSharers' concept is an appealing one from an intuitive and dis-
tributive justice perspective: it seems only fair that people who agree to
donate organs should receive priority if they ever need one.257 Scholar Al-
exander Tabarrok agrees, proposing a "no give, no take" policy with re-
spect to organs: if one does not agree to be a donor, one should not be al-
lowed to receive the benefit of donated organs.258 Ironically, approximately
70% of today's transplanted organs go to recipients who are not donors
themselves, while thousands of those who are willing to be donors go
without.259 All else equal, the scarce supply of human organs should be
allocated first to individuals who themselves are willing to sacrifice to save
other people's lives. While LifeSharers has implemented this priority ac-
cess concept on a grass roots basis, UNOS could modify its allocation rules
to implement it immediately on a national scale.
Nevertheless, critics charge that the incentive scheme offered by
LifeSharers discriminates against certain populations who cannot donate
because of religious or cultural reasons, and who would therefore be disad-
(2003) (discussing adverse selection in insurance markets).
256 See LifeSharers, Frequently Asked Questions, supra note 254 (noting that LifeSharers members
do not qualify for preferential access to organs from other LifeSharers members until they have been a
member for 180 days).
257 See LifeSharers, LifeSharers People, at http://lifesharers.com/people.htm (last visited Nov. 5,
2004) [hereinafter LifeSharers People] (quoting Steve Calandrillo). See also Steve P. Calandrillo's
Comments in Response to David Wessel's June 17, 2004 Capital Exchange Column: Easing the Organ
Shortage. David Wessel, Capital Exchange Column, How to Unite Patients with Organs They Need?,
WALL ST. J. ONLINE, June 22, 2004. (including Calandrillo's response) [hereinafter Calandrillo, Re-
sponse to Easing the Organ Shortage]. Adam Kolber also has analyzed the issue of whether priority
rules should be based on one's willingness to donate. See Kolber, supra note 118.
258 See Tabarrok, supra note 6. Tabarrok also suggests awarding "extra points" to the priority
position of those individuals in need of organs if they also agree to become donors themselves. See id.
259 See LifeSharers, Frequently Asked Questions, supra note 254 (noting that people who have
signed up as donors only receive approximately 30% of the organs transplanted in the United States).
Individuals who are willing to accept donated organs, but not willing to donate their own organs, are
classic "free-riders." They benefit from the altruistic acts of others, but are not willing to pay the same
price that their more generous counterparts do. Free-rider problems must generally be cured with some
kind of government intervention-otherwise, every individual's private incentive is to opt out, while
benefiting from others who opt in. It does not take long to realize that when everyone has an incentive
to free ride, extremely few people are motivated to opt in. For a discussion of the free rider problem in
other contexts, see Steve P. Calandrillo, Vanishing Vaccinations: Why Are So Many Americans Opting
Out of Vaccinating Their Children?, 37 U. MICH. J. L. REFORM 353, 420 (2004), lamenting free riding
in the childhood immunization context) and Calandrillo, supra note 255, at 461, raising the need to
prevent the free rider problem in the context of private supply of public goods, such as roads.
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vantaged by their inability to join.26 ° Further, some argue that it gives
members false hope, primarily because there are not enough people on the
organization's membership roster yet to constitute a reliable supply of or-
gans. 261 However, membership has more than doubled in each of LifeShar-
ers first two years of existence.262 If LifeSharers continues to grow at this
exponential rate, there would be more than one million members-all po-
tential donors-by 2013.263
2. Paired Organ Exchanges
Analogous to LifeSharers' concept of giving priority to those who
themselves are willing donors, "paired organ exchanges" are a form of
moneyless market that provides strong incentives to individuals to donate
so that they also might be able to receive an organ. 264 The idea is simple:
many people in need of organs have siblings or other relatives who are
260 See Carol M. Ostrom, The Search for Organ Donors: How Far is Too Far?, SEATTLE TIMES,
Mar. 21, 2004, at Al. However, despite popular belief, nearly all major religious denominations ap-
prove of organ donation. See infra Part IV.B.6.
261 See Ostrom, supra note 260.
262 See LifeSharers Celebrates Second Anniversary: Grass-Roots Organ Donors Network Notes
Progress and Accomplishments, LIFESHARERS PRESS RELEASE (LifeSharers, Nashville, Tenn.), May 22,
2004, at http://www.lifesharers.com/pressrelease20040522.htm (last visited April 5, 2005). As of Octo-
ber 31, 2004, LifeSharers had 2,628 members, compared to just 1,651 members twelve months prior.
See Our Newsletter, LIFESHARERS MEMBERS NEWSLETTER (LifeSharers, Nashville, Tenn.), November
2004, at http:/ilifesharers.comi/newsletter.htm (last visited Nov. 15, 2004).
263 Unfortunately, the growth rate of most organizations tends to slow down as they become larger,
so it may take more than another nine years to hit the one million member mark. Executive Director
Dave Undis notes, however, that the growth rate may not actually diminish because "LifeSharers is a
classic case of the network effect-as our membership grows, the value of joining goes up. Sooner or
later one of our members will get an organ from another member (an organ that they wouldn't have
gotten if they hadn't been a member), and the publicity we'll get from this should cause our member-
ship growth to accelerate." See Email from Dave Undis, Executive Director, LifeSharers, to Steve
Calandrillo, Advisor, LifeSharers (Sept. 17, 2004 10:31 AM) (on file with author).
264 See Morley, supra note 19, at 223-24. Morley asserts:
[F]ederal law should be amended so as to allow the already-existing registry of patients in
need of organ transplants to bring together the families and friends of different patients on
the waiting list in order to save lives .... A system of paired organ exchanges would facili-
tate transplantation in situations where a friend or family member of Patient A is incompati-
ble with him, but would be compatible with some other person on the waiting list (Patient
B), and a close friend or family member of Patient B is incompatible with her, but compati-
ble with Patient A. The family member of patient A would donate a compatible nonvital or-
gan to patient B, on the condition that the family member of patient B donates a compatible
nonvital organ to patient A; hence the phrase "paired organ exchange .... "
This system would, of course, be limited to the exchange of nonvital or regenerable organs
(kidneys and livers), where donation would not endanger the donor or adversely impact the
donor's major life activities.
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willing to donate organs to their loved one in an attempt to save their life.
However, these relatives may not be blood-type matches, or the sick person
may possess antibodies that could render her family member's organs un-
suitable for transplantation.2 65 While they writhe in agony wishing they
could do something to help their relative directly, there is often another
unrelated person on the nationwide waitlist who would be a good match for
their organs. Few people are willing to donate a kidney to a stranger-but
they would change their mind in a heartbeat if someone from the stranger's
family had a kidney that matched their relative's blood and tissue type.
Where two strangers (or their families) have organs that are compatible
with each other, the law should facilitate a paired organ exchange immedi-
ately-in effect, boosting the priority of each individual to receive a trans-
plant based on the fact that she (or her family member) donates an organ
that saves someone else's life.266 It seems only reasonable that we should
move a person to the head of waitlist if she or her family donates an organ
to save someone else.
Paired organ exchanges accomplish the dual purposes of incentivizing
people to donate organs who otherwise might not (by using self-interest as
motivation), while also avoiding the payment of valuable consideration for
human organs (and its host of accompanying concerns). 267 Given these vir-
tues, scholars such as Michael Morley advocate that the law should not
only permit, but actively promote, paired organ exchanges by individuals
(and their family members) who are currently on the nationwide organ
waitlist.268 Morley proposes to do this by modifying the existing national
database of patients in need of organs to include information about indi-
viduals potentially willing to donate on behalf of each patient, and using
this data to identify cross-matches.269 In this manner, "the government
could bring together compatible donors and recipients who would other-
wise never meet, and in each successful case allow two transplants to occur
that might otherwise be impossible. 27 °
The paired organ exchange concept has been largely overlooked in the
organ donation debate, but its obvious benefits have begun to receive
265 See id. at 226-29; Wessel, supra note 19 (noting that a biological barrier often prevents a trans-
plant from a relative).
266 It is easy to see the parallels to LifeSharers' philosophy-where one is willing to donate, they
should be given higher priority in receiving a transplant themselves.
267 UNOS received a legal opinion that these types of paired organ exchanges do not involve
"valuable consideration." See Legal Opinion from William Mullen, Intended Recipient Exchanges,
Paired Exchanges and NOTA § 301 (Mar. 7, 2003) (on file with author).
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greater attention very recently.27 1 MatchingDonors.com has put into place
an analogous idea that capitalizes on the fact that there are numerous donor-
recipient matches possible nationwide that are not being taken advantage
of-simply because donor and recipient do not know each other exists.272
Hence, in exchange for a fee, the company provides "a venue where pa-
tients and potential donors can meet and communicate" to find those avail-
able donor-recipient connections which otherwise would never be made.273
In addition, the pure paired organ exchange solution received national at-
tention in June, 2004, when the Wall Street Journal profiled a group of
physicians at Massachusetts General Hospital and Johns Hopkins engaging
in the practice.274 With help from Harvard economist Alvin Roth, these
physicians designed a "moneyless market"275-by linking people in need
with others in need, they create an exchange based not on dollars but on
suitable organs. One example profiled is that of a New England father with
blood type A who could not donate a kidney to his daughter with blood
type B.276 With the coordination of various transplant centers, he gave a
kidney to a teenager (a stranger) with blood type A, and the teenager's sis-
ter gave a kidney for the man's daughter.2 77 These transplant centers have
even begun organ swaps involving three different people or families in
need, but doing so necessarily entails increased complexity to work out the
logistical details.278 These difficulties are well worth it, however, when one
considers that 2,000 or more people could receive transplants annually if
there were simply a national database that included donors who were will-
ing to engage in these kind of paired organ exchanges. 279
271 See id. at 223.
272 See MatchingDonors.com, at http://matchingdonors.com/life/index.cfm (last visited April 5,
2005).
273 Id. Critics charge, however, that the service takes advantage of desperate people, opens the door
to payment for organs, and manipulates the system so that wealthy individuals are more likely to receive
transplants. See Ostrom, supra note 260.




278 See id. Doctors and hospitals have worked out some rules to facilitate exchanges and control
complexity-the donor must travel to the hospital where the recipient is; participants may keep their
identities private if they so choose; all surgeries in a swap begin simultaneously to avoid anyone back-
ing out halfway through the exchange. See id.
279 See id. The 2,000 lives saved figure is a projection made by Johns Hopkins transplant surgeon
Robert Montgomery. I should also be careful to note that there are two distinct types of paired-organ
exchanges possible: (1) I give a kidney to your sister and you give one to my brother, and (2) I give a
kidney to someone on the waiting list and my brother receives priority access to kidneys from cadaveric
donors across the country. See id.
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Thus, even if paying money in return for human organs is never mor-
ally acceptable, moneyless markets that allow for paired organ exchanges
can serve as an important, far less objectionable step in the right direc-
280tion.
3. Presumed Consent
Public opinion surveys consistently demonstrate overwhelming sup-
port for organ donation, on the order of 80% or more.28 ' At the same time,
less than three out of every ten people has signed up to become a donor. 82
This paradox is hard to swallow if you are one of the seventeen Americans
who will die today because no organ was found in time.283 Each death
highlights the reality that America's organ shortage is not due to a lack of
potentially life-saving organs, but rather, the fact that the vast majority of
them are taken to the grave with their owner.
One method of correcting this tragic disparity is to presume that all in-
dividuals consent to have their organs donated upon death unless they have
expressly opted out during their lifetime-an opt-out rather than an opt-in
system.284 Doing so would take advantage of the strong public consensus in
favor of donation, while simultaneously overcoming the minimal barriers
there are to having to affirmatively sign up to become an organ donor to-
day. Despite the fact that checking the organ donor box on one's driver's
280 See Calandrillo, Comments in Response to Easing the Organ Shortage, supra note 257.
281 See The Gallup Organization, Inc., supra note 10 (85% of those polled were in favor of organ
donation by a loved one and 60% said they would be willing to donate their own organs); Pew Research
Center for the People and the Press, supra note 10 (81% of respondents supported organ donation).
282 See The Gallup Organization, Inc., supra note 10 (28% of Americans surveyed had registered
as organ donors); Hansmann, supra note 9, at 60 n.9 (citing to a 1985 study indicating that only 17% of
Americans had completed organ donor cards).
283 See Living Legacy Registry, supra note 3.
284 See, e.g., Linda C. Fentiman, Organ Donation as National Service: A Proposes Federal Organ
Donation Law, 27 SUFFOLK U. L. REV. 1593, 1607-09 (1993) (exploring a presumed compensated
donation system); Kelly Ann Keller, The Bed of Life: A Discussion of Organ Donation, Its Legal and
Scientific History, and a Recommended "Opt-Out" Solution to Organ Scarcity, 32 STETSON L. REV.
855 (2003); Daphne D. Sipes, Does it Matter Whether There is Public Policy or Presumed Consent in
Organ Transplantation?, 12 WHITTIER L. REV. 505 (1991); Williams, supra note 105, at 317-18 (advo-
cating for the "worldwide harmonization of domestic legislation, which would ... presum[e] the con-
sent of the individual to donate organs while maintaining the option to withdraw consent .... "). Of
course, we could go beyond presumed consent all the way to a mandatory organ conscription system,
but that would raise far more opposition than a system that allowed individuals to opt out. See, e.g., Eric
Cohen, supra note 8, at 115 (criticizing various alternatives to increase organ donation, including pre-
sumed consent and conscription). Somewhere in the middle would be a system that forced individuals to
either opt-in or opt-out before they were allowed to receive their driver's license. For minors, we could
require that parents make the decision for their child when they applied for a social security number.
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license seems easy, many academics have detailed the psychological barri-
ers that prevent individuals or their families from consenting to donation at
the time of their death.285 It is reasonable to suspect that switching to an
opt-out system in the U.S. would lead to far higher organ donor participa-
tion rates than those currently realized. In fact, consistent with this under-
lying hypothesis, data indicate that such policies are effective at increasing
the rate of organ procurement from eligible individuals.286
In fact, many European nations, including Austria, Denmark, France,
Poland and Switzerland, utilize a presumed consent system in which the
decedent's organs can be removed regardless of her family's wishes unless
the deceased had expressly opted out.287 A more mild system is employed
by Finland, Greece, Italy, Norway, Spain, and Sweden, where the dece-
dent's family can prevent organ removal by exercising their right to object
to it after their loved one's death.288 An interesting hybrid regime exists in
Singapore, where citizens are assumed to consent to donation, unless they
are members of certain religious groups, including Islam. 289 This type of
balanced system incorporates both public consensus in favor of donation,
while respecting the beliefs of groups which would likely opt out if given
the choice.
Despite the thousands of lives that would be saved, the most signifi-
cant obstacle to enacting a presumed consent system in the U.S. is our
strong tradition of individual freedom and autonomy.2 90 Presuming that an
individual has agreed to donate her organs runs afoul of many people's core
beliefs in liberty and freedom from government interference. We would be
forced to incur the risk that some individuals would have their organs har-
vested who otherwise would have exercised their right to refuse if they
knew they could have. Even with stringent safeguards to protect these indi-
285 See Hazony, supra note 60, at 240-41. Hazony describes the need for both families and medical
professionals to overcome the emotional obstacles inherent in donation. Id. However, she believes that
better training and education of both groups can reduce the disparity between those who support dona-
tion and those who actually do it, without the need to resort to a system of presumed consent. Id. Na-
tional Kidney Foundation data indicate that 35% of families do not consent to organ donation when
their deceased relative would be a suitable candidate. See National Kidney Foundation, supra note 9.
286 See L. Roels et al., Effect of a Presumed Consent Law on Organ Retrieval in Belgium, 22
TRANSPLANT. PROC. 2078, 2079 (1989).
287 See Kurtz and Saks, supra note 21, at 778-79.
288 See id. However, the burden of opting out is a non-trivial one because physicians are not re-
quired to advise families of their right to refuse. Id. Presumed consent systems exist outside of the
European continent as well. See, e.g., Everton Bailey, Should the State Have Rights to Your Organs?
Dissecting Brazil's Mandatory Organ Donation Law, 30 U. MIAMI INTER-AM. L. REV. 707 (1999).
289 See Patricia Tsao, Singapore's Presumed Consent/Explicit Consent Hybrid Organ Donation
Law: A Potential Model for the U.S. (manuscript on file with author).
290 See Kurtz and Saks, supra note 21, at 779 (citing Albert R. Jonsen, Transplantation of Fetal
Tissue: An Ethicist's Viewpoint, 36 CLIN. RESEARCH 215 (1988)).
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viduals, it would be difficult to completely eliminate the risk that some-
one's autonomy would be violated.
However, a few states have enacted extremely limited forms of pre-
sumed consent legislation, including statutes that allow coroners to remove
a decedent's corneas absent an objection from their family, or after fair
inquiry to ascertain whether such an objection exists. 291 These laws have
largely survived constitutional due process and takings clause challenges.292
However, any effort to expand the notion of presumed consent to allow for
the harvesting of all suitable organs at death would likely meet stiff politi-
cal and constitutional resistance. 93 As a practical matter, it will be chal-
lenging to overcome our traditional emphasis on freedom and voluntary
action to muster the political will to promulgate broad-ranging presumed
consent legislation. But, by juxtaposing the decision regarding presumed
consent legislation against the inevitable lives that will be lost without it,
perhaps some reasonable minds can be influenced in its favor.
4. Required Request
Even if we cannot gain consensus in America to move to a presumed
consent system, we have shown the political and legal will to require hos-
pitals, or other medical care providers, to ask the decedent's family to do-
nate her organs at the time of her death. The 1987 revision to the UAGA
called for health care professionals to ask families of individuals to consent
to organ donation if their loved one had not already signed an organ donor
card.294 Various states have also enacted some form of "required request"
291 See Cate, supra note 228, at 84 n. 115 (providing a collection of statutes); Unif. Anatomical Gift
Act of 1987 § 4(a), 8A U.L.A. at 43.
292 See Erik S. Jaffe, She's Got Bette Davis('s) Eyes: Assessing the Nonconsensual Removal of
Cadaver Organs Under the Takings and Due Process Clauses, 90 COLUM. L. REV. 528, 538-42 (1990);
Kurtz & Saks, supra note 21, at 779 n.40. Kurtz and Saks cite to State v. Powell, 497 So.2d 1188 (Fla.
1986) ("rejecting both due process and takings clause challenges") and Georgia Lions Eye Bank v.
Lavant, 355 S.E.2d 127 (Ga. 1985) ("rejecting a due process challenge"). Id. However, the Sixth Circuit
has held that removal of corneas is an unconstitutional taking of property without due process where
medical records revealed decedent's wife refused to make a gift. See Brotherton v. Cleveland, 923 F.2d
477 (1991).
293 Kurtz and Saks further posit that presumed consent statutes might be vulnerable to First
Amendment challenge, at least where the donor is known to have a religious objection. See Kurtz and
Saks, supra note 21, at 779, n.40 (citing to N.Y. Pub. Health Law § 4222 (McKinney 1978); Ohio Rev.
Code Ann. § 2108.53 (West 1978)).
294 Unif. Anatomical Gift Act § 3. All hospitals are required by law to have a "Required Referral"
system in place. Under it, the hospital must notify the local Organ Procurement Organization (OPO) of
all patient deaths. If the OPO determines that organ and/or tissue donation is appropriate in a particular
case, they will have a representative contact the deceased patient's family to offer them the option of
donating their loved one's organs and tissues. See The National Kidney Foundation, supra note 9; see
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legislation.295 There is still debate, however, over who should be doing the
asking (i.e., doctor, nurse, hospital staff, or OPO representative), and
whether or not it will work in practice.
Frankly, results of required request policies have not been as good as
hoped for.296 Orly Hazony offers a possible hypothesis to explain this out-
come. 297 He suggests that psychological issues relating to organ procure-
ment negatively impact the legal systems designed to encourage dona-
tion.298 Emotional issues involved may deter the decedent's family from
agreeing to donation, as well as prevent health care professionals from
feeling comfortable enough to sensitively request donation from the fam-
ily.299 Therefore, Hazony posits that the solution to the organ shortage lies
in addressing the psychological issues involved in procurement rather than
adopting more restrictive legal regimes (e.g., presumed consent).300 By
educating health providers about the need to ask families for consent and by
providing training that allows them to do so in a manner that respects the
family's grieving, 301 Hazony argues that we could significantly increase
organ donor participation rates.
Thus, legally mandating that health care providers ask for organs is
not likely to have a dramatic impact if done alone. Required request statutes
need to be accompanied by training, education and public awareness cam-
paigns if they are to have the impact on organ procurement rates that was
initially hoped for. Their role is important, however, in sending a clear sig-
nal that we cannot ignore the organ shortage in America simply because
addressing it involves issues that are difficult for physicians and families to
discuss.
also Arlene Judith Klotzko, Mankind's New Best Friend, CHI. TRIB., Aug. 22, 1999, § 2, at 1 (describ-
ing today's organ donation system as one in which individuals either sign donor cards prior to death, or
where their families are asked to give consent to organ donation afterwards).
295 See Hansmann, supra note 9, at 61.
296 See Hazony, supra note 60, at 231 (citing to Maxwell J. Mehlman, Presumed Consent to Organ
Donation: A Reevaluation, 1 HEALTH MATRIX 31 (1991)).
297 See id at 220.
298 See id. at 236-39.
299 See id.
300 See id. at 256-57.
301 See id. at 246-51. Other commentators have urged that hospitals be held legally liable if they do
not ascertain a patient's wishes regarding organ donation. See, e.g., Christine E. Edwards, Giving Vir-
ginia's Anatomical Gift Code Life: Creating Liability for a Hospital's Failure to Determine Donative
Intent, 47 WASH. U. J. URB. & CONTEMP. L. 185 (1995).
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5. National Donor Registry
While there is a national organ waitlist administered by UNOS that
contains over 85,000 names, it might come as a surprise that no cohesive
counterpart exists that tracks willing organ donors. The formation of a na-
tional donor registry would be a significant, commonsense step towards
putting these two groups of individuals together to save thousands of lives
that do not need to be lost.30 2
Phyllis Coleman has argued for such a database, stating that a national
computer registry containing donor status, and other relevant information
such as blood type, is one essential way to effectuate transplants that might
otherwise never happen.30 3 Further, paired organ exchanges would flourish
if such a registry existed by allowing individuals on the waitlist, and their
family members, to dramatically increase their chances of finding a suitable
swap. 30 4 Today, organizations like MatchingDonors.com purport to provide
this type of searching service, 305 but charge substantial fees.3" Further, their
efforts could undoubtedly be more successful if a federal registry was es-
tablished to serve this very purpose.
Thus, a national donor registry could be instrumental in saving many
lives without requiring that a single dime be paid by organ recipients to
donors. However, federal funds would be necessary to create, maintain and
update the registry in the first instance. 30 7 From a public policy perspective,
302 See World Medical Association, Statement on Human Organ and Tissue Donation and Trans-
plantation, at http://www.wma.net/e/policy/wma.htm (last visited April 5, 2005). The WMA believes
that physicians are the actors in the best position to increase organ donation, and recommends exploring
the formation of a national donor registry to accomplish this goal. See id. To date, there has been a
proliferation of state organ donor registries, but there is no coherent link between them.
303 See Coleman, supra note 72, at 2-3. Coleman details a national computer registry that would
contain donor status and other relevant information, such as potential donors' blood type and whether
the person has a living will. Id. She argues that states would need to "create and continuously update
such a registry, and draft and implement detailed procedures for police and emergency medical person-
nel to follow in certain accident and trauma situations. Under these guidelines, law enforcement offi-
cers, paramedics, and hospital personnel would be required to ascertain donor status by checking with
the national computer system as soon as possible." Id.
304 See Morley, supra note 19, at 239.
305 See MatchingDonors.com, supra note 272.
306 See Ostrom, supra note 260 (noting that critics of MatchingDonors.com point out the fact that
the service is available only for a fee, giving wealthy individuals better access to available organs than
their poorer counterparts).
307 See Coleman, supra note 72, at 2 (noting that the computer database proposal would be a more
costly one compared to other alternatives, but advocating for it nonetheless given its potential benefits).
Washington congressman Jay Inslee proposed a bill that would have allowed this expenditure (The
Organ Donor Enhancement Act), but it never emerged from the House Subcommittee on Health. H.R.
955, 107th Cong. (2001). On the other hand, organizations such as LifeSharers have the potential to
evolve into a national organ donor registry-but one which would not be administered by UNOS nor
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it seems like this expenditure would be easily justified by the concomitant
benefits attached.
6. Public Awareness Campaign
Finally, none of the previously mentioned incentive schemes or pro-
posed solutions to the nation's organ crisis will be successful without an
aggressive public awareness and education campaign backing them up.
308
Americans are generally aware that people die while on national organ
waitlists, but few realize the staggering magnitude of the problem.309 The
media pays far more attention to individual deaths from earthquakes or
tornadoes than it does to the thousands of annual deaths from kidney fail-
ure31 -even though the latter are far more preventable than natural disas-
ters.
As a first step, we must educate America about the crisis and correct
the rampant myths and urban legends that continue to surround organ do-
nation.311 Many Americans are in favor of donation but still fear that if they
signed up to become a donor, then doctors will not try as diligently to save
their life if they were involved in an accident that presented a chance for
organ harvesting.312 Some are deterred because they believe that their fain-
require the expenditure of scarce public funds.
308 See Hazony, supra note 60, at 221. But cf Conan, supra note 43 (claiming that advertising
regarding organ donation has not been successful); Jurgensen, supra note 59 (stating that the millions of
dollars spent on public awareness has done little good).
309 For instance, far more Americans die while on the national organ waitlist each year than the
number of people who die annually from tornadoes, floods, lightning, landslides and earthquakes com-
bined. See Fred Schwab, Geologic Assessment: Alan Greenspan or Pete Rose, at
http://www.geotimes.org/june04/column.html (last visited April 5, 2005).
310 See generally Steve P. Calandrillo, Responsible Regulation: A Sensible Cost-Benefit Risk versus
Risk Approach to Federal Health and Safety Regulation, 81 B.U. L. REV. 957, 1000-01, 1001 n.198
(2001) (detailing the public's overreaction to high tragedy but low probability events like earthquake,
flood and fire, and the public's simultaneous underperception of far more common risks like heart
disease and cancer.).
311 See Alexandra K. Glazier, "The Brain Dead Patient was Kept Alive" and Other Disturbing
Misconceptions: A Call for Amendments to the Uniforn Anatomical Gift Act, 9 KAN. J.L. & PUB. POL'Y
640 (2000) (discussing the rampant urban myths surrounding organ donation and their potential to
undermine public confidence in the donation process).
312 See U.S. DEP'T OF HEALTH & HUMAN SERVICES, ORGAN DONATION, at
http://www.organdonor.gov/myth.html (last visited April 5, 2005) [hereinafter ORGAN DONATION]
(stating that "[o]rgan and tissue recovery takes place only after all efforts to save your life have been
exhausted and death has been legally declared. The medical team treating you is completely separate
from the transplant team. The organ procurement organization (OPO) is not notified until all lifesaving
efforts have failed and death has been determined."). Despite these assurances, a rational choice theorist
2004]
GEO. MASON L. REv.
ily will be charged for the medical expenses associated with donating their
organs.313 Others think they are too old to be useful donors or that waitlist
priority is influenced by celebrity status.314 In addition, we must correct
misperceptions that most religions are opposed to donation.315 In fact,
nearly all major religious denominations-including Christianity and Juda-
ism-affirmatively support organ donation where human lives can be
saved.316 Furthermore, some Americans would be willing to donate but
choose not to because they think their bodies will be disfigured by organ
harvesting, preventing an open casket funeral and causing emotional dis-
tress to loved ones.317
Mainstream advertising and public awareness campaigns will be nec-
essary if we are to overcome the misunderstandings and outright myths that
hamper organ donation participation rates today. Congress and President
Bush have just taken a solid step in this direction by promulgating the Or-
gan Donation and Recovery Improvement Act earlier this year.318 The leg-
islation provides $5 million annually from 2005 through 2009 to fund pub-
lic awareness efforts and to study ways to increase recovery and donation
would find it predictable that some patients may fear that physicians will not exhaust all potentially life-
saving efforts if they think that failing to do so will yield a harvestable organ. Furthermore, while brain
death is the standard for determining death today, one commentator has urged that we redefine death to
include cardiac death in order to increase the available pool of donors. See Marla K. Clark, Solving the
Kidney Shortage Crisis Through the Use Of Non-Heart-Beating Cadaveric Donors: Legal Endorsement
of Perfusion as a Standard Procedure, 70 IND. L.J. 929 (1995). There has also been a recently reported
case of an organ being harvested from a person who was possibly not yet brain dead. Organs Harvested
Prematurely?, CBSNE W S .C 0 M a v a i l a b l e at
http://www.cbsnews.com/stories/2004/l0/05/national/main647467.shtml (last visited April 13, 2005).
313 See ORGAN DONATION, supra note 312. Donation costs nothing to the donor's family or estate.
314 See Coalition on Donation, Donate Life-Get the Facts, Myths and Facts, at
http://www.shareyourlife.org/facts.html (last visited April 5, 2005). People of all ages and medical
histories should consider themselves potential donors-it is one's medical condition at the time of death
that will determine what organs and tissue can be donated. Further, priority is not influenced by celeb-
rity, but rather the severity of one's illness, time spent on the waiting list already, blood type and other
relevant medical information.
315 See LifeCenter Northwest, Religious Beliefs About Donation, a I
http://www.lcnw.org/facts/religious/index.html (last visited April 5, 2005) (noting that most major
religions in the U.S. approve of organ and tissue donation and consider it an act of charity).
316 See Mayoclinic.com, Organ Donation: Don't Let Myths Stand In Your Way, at
http://www.cnn.com/HEALTH/library/FL/00077.html (last visited April 5, 2005) (stating that organ
donation is consistent with the beliefs of all larger religious denominations in the United States, includ-
ing Catholicism, Protestantism and most branches of Judaism.).
317 See ORGAN DONATION, supra note 312 (refuting the notion that donation mutilates the body,
and noting that an open casket funeral is still possible).
318 Organ Donation & Recovery Improvement Act, Pub. L. No. 108-216, 118 Stat. 584 (2004).
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rates.319 At the state level, a few pilot programs to spur organ donation have
recently been enacted. Delaware, for instance, has created an Organ and
Tissue Donation Awareness Trust Fund charged with developing donor
awareness programs, instituting educational programs in high schools, and
creating an awareness campaign for state employees.32° Florida followed
suit by instituting an Organ and Tissue Donor Education and Procurement
Trust Fund that accepts voluntary donations of one dollar as part of the
collection process for licensing taxes.12 The money is used to operate the
state's organ certification program, maintain the organ and tissue donor
registry, and educate the public regarding the need for organ and tissue
donation.3 22 Ohio's Second Chance Trust Fund is even broader in scope, as
it accepts voluntary contributions that are used to (1) implement statewide
public education programs about organ, tissue, and eye donation, (2) in-
crease awareness in high schools, (3) recognize donor families, (4) develop
hospital training programs, and (5) reimburse relevant parties for adminis-
trative costs. 323 Finally, New York proposed a bill which would amend its
tax law, public health law, and the vehicle and traffic law to establish a
"Gift of Life" trust fund.324
Moreover, the media can dramatically increase organ donation simply
by paying greater attention to the issue. When Californian Nicholas Green
was murdered in Italy, his family agreed to donate his organs, saving seven
Italians in the process. In the following days, the donor card signatory rate
increased in Italy by 400%.325 Closer to home, when former NBA star
Alonzo Mourning was forced to retire due to kidney failure, discussion
regarding the benefits and dire need for organ donation surged in Amer-
ica.326 Sadly, it should not take a tragedy to spur organ donation participa-
tion rates, but it seems that tragedies make for the best fodder on the eve-
ning news.
319 See Organ Donation & Recovery Improvement Act § 377(f).
320 DEL. CODE ANN. tit. 16, §§ 2710, 2730(a)-(b) (Supp. 1998).
321 FLA. STAT. ANN. § 320.08047 (West Supp. 2000). A similar program is underway in Tennes-
see, where individuals are asked to donate $1 to increase organ donation awareness when they get or
renew their driver's license. See County Clerk, You May Save a Life, at
http://www.countyclerkanytime.com/donor/default.htm (last visited April 5, 2005).
322 See DEL. CODE ANN. tit. 16, §§ 2710, 2730(a)-(b) (Supp. 1998); FLA. STAT. ANN. § 320.08047
(West Supp. 2000); Siegel, supra note 23, at 943 (discussing various initiatives to increase public
awareness regarding the need for organ donation).
323 OHIO REV. CODE ANN. §§ 2108.15(A)-(H), 4506.081 (Anderson 1999).
324 S. 7759, N.Y. 223rd Sess. (N.Y. 1999). Unfortunately, the bill ended up in committee and was
never passed into law.
325 See Barbara Sofer, Change of Heart, THE JERUSALEM POST, Aug. 3, 2001, at 10.
326 See LifeSharers Blog, Nov. 30, 2003, a I
http://Iifesharers.blogspot.com/2003_11 01_lifesharersarchive.html (last visited April 5, 2005).
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CONCLUSION
All across the world today, physicians, hospitals, organ brokers, and
the entire organ transplantation support industry make millions of dollars
by saving people's lives when organs are found for those in desperate need.
In the United States, the only parties who receive no compensation at all are
the donor and her family. Some families bury their loved ones in unmarked
graves because they cannot afford headstones, while various health care
middlemen make thousands from the organs harvested.3 27
The ban on human organ sales in America was founded upon the no-
ble intention that organs should provide the ultimate "gift" of life, not one
that requires purchase on the open market. Sadly, that goal has yet to mate-
rialize-organ transplants are still prohibitively expensive for recipients,
doctors and hospitals mark up their price tags to take advantage of desper-
ate individuals' extreme willingness to pay to avoid death, and there is little
in the way of government control over various black markets thriving
worldwide. The poor are exploited into selling kidneys thinking that they
will escape debt, only to find themselves in continued financial hardship
down the road, accompanied now by deteriorated health status.
Is the solution legalized human organ sales? I don't know. Practically
speaking, it is unlikely that human organ sales will ever achieve societal
acceptance due to legitimate fears of abuse and exploitation. However,
those dangers could be substantially safeguarded against by a responsible
regulatory regime inside the U.S. To combat sellers' imperfect information
problems, full risk-disclosure would be required. To address distributive
justice inequities, purchases by the poor could be fully subsidized. To pre-
vent negative externalities from falling on the state, health insurance for
sellers would be mandated.
Given the risks associated with living-donor sales, however, society
would be well advised to turn its energies towards exploring other means of
incentivizing organ donation. Both monetary and nonmonetary incentives
have to date been largely ignored by federal and state governments, but
present the real potential to cure our nation's organ crisis. Futures markets
that allow for organ sale, but harvesting only at death, are an intriguing way
to take advantage of market supply and demand while avoiding the dangers
of living-donor sales.3 28 More modest proposals include burial compensa-
tion or tax breaks to donors or their families.329 Combining tax credits with
discounted driver's license fees could take advantage of the American pub-
327 See Young, supra note 8.
328 See supra Part IV.A. I (discussing proposals for futures markets outlined by Cohen, Crespi, and
Hansmann).
329 See supra Parts IV.A.2 and IV.A.4.
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lic's strong support for donation which unfortunately has yet to translate
into widespread organ donor status.
330
Moreover, a plethora of nonmonetary incentives exist that could spur
organ donation and procurement without running afoul of NOTA's prohi-
bition on paying "valuable consideration" for human organs. By linking
waitlist priority with an individual's own willingness to donate, organiza-
tions like LifeSharers incentivize people to sign up to become donors who
otherwise might not, if only out of pure self-interest.331 Paired organ ex-
changes that allow for swaps between individuals with family members in
need hold tremendous promise in encouraging donation without requiring a
single dime in return.332 Presumed consent and required request statutes
could capitalize on the overwhelming public consensus in favor of donation
that often goes unacted upon today.333 A computerized national registry of
organ donors would make large strides in linking patients with willing indi-
viduals to create matches that they simply do not know are out there to-
day.334 Finally, all of the above proposed solutions depend largely on en-
hanced public awareness and education regarding the current organ crisis
and what steps Americans can take to overcome it.
33 5
In the final analysis, we must critically reexamine organ donation law
and policy in the United States to ascertain why its life-saving potential has
never been fully realized. If we cannot or will not do so because the topic
strikes an uncomfortable nerve in our conscience, many more thousands of
Americans will pay with their lives for our failures.
330 See supra Part IV.A.3.
331 See supra Part IV.B. 1.
332 See supra Part IV.B.2.
333 See supra Parts IV.B.3 and IV.B.4.
334 See supra Part IV.B.5.
335 See supra Part IV.B.6.
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